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ABSTRACT
Healthy People has projected depression to be the primary cause of disability by 2020; therefore routine
depression screening has been prioritized as a national healthcare initiative. The purpose of this
Evidence-Based Practice (EBP) project is to demonstrate that routine implementation of the 2-item
Patient Health Questionnaire (PHQ-2) depression screener, along with a scheduled follow-up protocol for
adults in the primary care setting, can improve current mental health practices regarding the identification
of depression by clinicians. The evidence supports use of the PHQ-2 for routine adult depression
screening, as long as a scheduled follow-up protocol is available for positive screens. This practice
change enables clinicians to accurately identify depressed adults, promptly intervene, and implement an
appropriate plan of care. The Iowa Model of Evidence-Based Practice and Kotter’s (1996) Eight Stages of
Change model expedited the implementation of this project. Data were collected during a one-month
implementation period and analyzed by the Statistical Package for Social Services (SPSS) Version 23.
Baseline data included the number of identified depressed adult patients based on clinical judgment in the
same timeframe the year prior. A total of 27 (N) patients were identified as depressed per the EBP
intervention. Comparing clinical judgment (3.49%) to the EBP intervention (20.19%) there was a
significant increase in the number of identified depressed adult patients. In summary, this EBP project
intervention increased the accuracy of the clinician’s identification of depression among adult patients in
the primary care setting. Implications for future practice would improve mental health assessment by the
clinician thus increasing the frequency and accuracy for diagnosing depression.
Keywords: Depression, patient health questionnaire, PHQ-2, primary care, screen.
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CHAPTER 1
INTRODUCTION
Evidence based practice (EBP) is at the foundation of the highest quality health care
practices and provides a safeguard for the best possible and most cost-efficient patient
outcomes (Melnyk & Fineout-Overholt, 2015). The melding of clinical expertise and EBP can
have significant effects on patient care by leading to superior patient outcomes. The
conscientious use of current best evidence reflects the dedication of advanced practice nurses
(APNs) to a problem-solving approach in clinical practice (Melnyk & Fineout-Overholt, 2015).
Implementation of patient care in the absence of current best evidence often results in futile
clinical interventions and is a disadvantage to patients (Melnyk & Fineout-Overholt, 2015). Thus,
the EBP process, combined with guidance from an EBP practice model and nursing theory,
enables the APN to provide the highest quality health care.
The initial step in the EBP process is to cultivate a spirit of inquiry, leading to formulation
of a compelling clinical question (Melnyk & Fineout-Overholt, 2015). The clinical questions
developed by the APN reflect examination of attitudes toward present practices and may
challenge current institutional practice guidelines. Cultivation of a spirit of inquiry is critical in
encouraging positive changes in practice Achieving successful organizational changes requires
that the APN have a clear vision, a strategic plan, and the persistence to see the plan to
completion (Melnyk & Fineout-Overholt, 2015). In the second step of the EBP process, the APN
searches for the best external evidence through a systematic and critical appraisal of relevant
research, clinical experience, and patient values; this evidence will be used to inform decisions
(Melnyk & Fineout-Overholt, 2015). The final steps of the EBP process include integration of the
EBP protocol into practice, evaluation of the process, and dissemination of the project findings.
The need for an EBP project was identified at a private Midwestern family practice clinic,
to focus on changing provider behavior in relation to depression screening and treatment of the
general adult population. The proposed practice change for this organization was the
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implementation of a routine depression screening tool accompanied by a follow-up scheduling
protocol. With these changes, clinicians would become better equipped to accurately identify
adults at risk for depression and to promptly intervene and implement an appropriate plan of
care.
The purpose of this EBP project was to implement a routine depression screen among
nonpregnant adults at a Midwestern family practice clinic, as well as a follow-up scheduling
protocol for positively screened patients. Doing so would integrate mental health assessment
into daily practice and would equip clinicians to make more educated decisions about patient
care. Chapter 1 provides background for this project, a statement of the problem, the compelling
clinical questions, the PICOT question, and a description of the significance of the project.
Background
Depression is a common mental health disorder that impacts an estimated 5% of the
global population (World Health Organization [WHO], 2016). Depression can be characterized
by prevalence of sadness, loss of interest or pleasure, feelings of guilt or low self-worth,
disturbed sleep or appetite, feelings of tiredness, and poor concentration (WHO, 2016).
Depression can be long lasting or intermittent, and its effects can substantially impair an
individual’s ability to function at work or school, or to cope with daily life. Severe depression is
highly correlated with incidence of suicide (O’Connor, Whitlock, Beil, & Gaynes, 2009).
When identified early, a mildly depressed person can be treated without medication;
however, when depression is identified later or as moderate to severe, patients require more
intense intervention, such as medication, professional referral for treatment, and a collaborative
care approach (WHO, 2016). Major depressive symptoms can be debilitating and can have
severely negative impacts on an individual’s quality of life (Löwe, Kroenke, Herzog, & Gräfe,
2003).
According to the WHO (2016), depression carries the heaviest burden of disability
among all mental health and behavioral disorders. In 2014, the National Survey on Drug Use
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and Health (NSDUH) found that an estimated 15.7 million adults (6.7% of the population aged
18 or older) in the United States experienced at least one major depressive episode in the past
year. According to the Centers for Disease Control and Prevention (CDC, 2014), depression is
most prevalent among female adults and has the highest occurrence among individuals aged 40
to 59 years old.
Depression has become an epidemic in the United States and is increasing in frequency.
Although this disorder affects less than 10% of the total patient population, treatment of
depression accounts for more than $43 billion in annual medical care costs (CDC, 2014;
Maurer, 2012). Originally, the U.S. Preventive Services Task Force (USPSTF, 2002)
recommended screening of adolescents and adults in clinical practices that have systems in
place to ensure accurate diagnosis, effective treatment and follow-up. Since then, the USPSFT
(2009) has included older adults in the recommending screening and treatment for depression
in older adult patients.
Within the realm of primary care, depression is estimated to affect 13% of patients
(O’Connor et al., 2009). Although considered to occur in a relatively small percentage of patient
encounters, experts project that rates of depression will continue to increase substantially and
that it will be a leading cause of disability by 2020 (Maurer, 2012). This is because most
depression goes undiagnosed, especially in older adults (aged 60 and older), in whom
depressive symptoms are viewed as normal in advancing age (Unützer et al., 2006).
Among the older adult demographic, an estimated 10% of general practice patients are
currently undiagnosed for depression (Almeida et al., 2012). According to the U.S. Department
of Health and Human Services (USDHHS; 2012), the U.S. population included 41.4 million older
adults in 2011, a significant (18%) increase since 2000. Therefore, due to the increasing
prevalence of depression in the general adult population and the number of undiagnosed older
adults in the United States, family practice is the most promising setting for early identification of
and swift intervention for depression.
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Along with increase in age and a higher prevalence among females, risk factors for
depression are correlated with several psychosocial and biological factors (CDC, 2014). Such
factors that increase one’s risk of depression include: history of chronic medical illness (i.e.
diabetes, heart disease, cancer, Parkinson’s disease), increase in number of chronic disease,
family history of depression, history of substance abuse, and social isolation (National Institute
of Mental Health [NIMH], 2016). Due to the increase of disease prevalence with advancing age,
depression risk factors should be carefully considered in all adults.
Statement of the Problem
The increasing number of aging adults in the American population has led to growing
concern about the number of under diagnosed depressed adults, which could escalate the
consequences of the depression epidemic. This section reviews the data that support this EBP
project, describes the need at the implementation site, and provides an outline of the purpose of
the project.
Data from the literature supporting the need for the project
In the United States, the need for early identification of depression and swift intervention
is a result, in part, of the underutilization of mental health services and is reflected in the
increasing rate of suicide among the general adult public (Simon et al., 2013; Unützer et al.,
2006), which is most significant among males (Van Orden et al., 2014). Although there are a
number of possible factors behind underutilization of mental health services, studies indicate
that social stigma toward seeking mental health care is the largest impediment to early
identification of depression (Botha & Dozois, 2015; Milner, Witt, Burnside, Wilson, &
LaMontagne, 2015).
Ageing is arguably one of life’s greatest challenges; however, depression should not be
considered normative with advancing age (Scazufca et al., 2016). Advances in health care
management have prolonged life expectancy, in turn extending the aging process and
increasing the likelihood that an adult will experience the emotional and physical effects
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associated with depression. Even more, open discussion of depressive symptoms with the
clinician may be perceived as daunting or embarrassing by some older patients. Such barriers
highlight the importance of routine assessment of this demographic for depression.
Stigmatization of mental health
Social stigmas about mental health needs, especially depression, can greatly impact an
individual’s desire to seek care (Botha & Dozois, 2015; Fleurantin, 2016; Milner et al., 2015).
Social stigmatization has been identified as one of the most significant barriers to early
identification of depression and is the primary contributor to underdiagnosis and poor quality
management (Botha & Dozois; Fleurantin, 2016; Miner et al., 2015). The effects of
stigmatization are generalizable to all age groups. However, mental health stigmas present a
major hindrance to the young and to older adults to seeking help for mental disorders including
depression (Almeida et al., 2012; Yap, Reavley, Mackinnon, & Jorm, 2013). According to the
National Institute of Mental Illness (NIMH), in 2012 an estimated 9.6 million adults (age 18 or
older) in the United States experienced mental health needs, such as depression management.
The underutilization of mental health services, minimal onset identification and premature
termination of mental health-related treatment are largely attributed to social stigmatization
(Pinto-Foltz & Logsdon, 2009); it is estimated that stigmas toward addressing mental health
account for 33% of undiagnosed depression in Americans each year (Fleurantin, 2016).
Practitioner recognition of the diverse effects of mental health stigmas and utilization of services
is an important factor in the integration and standardization of mental health assessments into
practice (Fleurantin, 2016). The implementation of routine depression screening will allow
general practitioners the ability to monitor an adult patient’s adaptation throughout life and will
present an opportunity to educate patients about stress management and coping strategies to
assist during significant life events.
Healthy People 2020 (USDHHS, 2012) recommends improved depression screening
and treatment rates among adults, with the mission of identifying health improvement priorities
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as well as critical research, evaluation, and data collection needs to improve the health of all
Americans. This initiative is aimed at increasing the proportion of primary care office visits that
screen adults for depression (USDHHS, 2012).
Due to the increased prevalence of mental health disorders and suicide among the
general population, as well as the recommendation to incorporate depression screening into
routine practice, this was an ideal time to implement an EBP project targeting the behavior of
general practice providers. Primary care provides the most promising setting for early
identification, routine screening, swift intervention, and collaborative follow-up throughout the
patient’s lifespan (Unützer et al., 2006). In turn, successful implementation can have a lasting
effect on the overall well-being of patients and can combat the local suicide rates.
Data from the clinical agency supporting the need for the project
Prior to implementation of the EBP project, a needs assessment was conducted to
determine the viability of a project focused on routine adult depression screening. It was found
that this Midwestern general practice did not have a routine depression screening or follow-up
scheduling protocol in place.
The site for this EBP project services and manages roughly 3,600 adult patients per
year. During the same timeframe the year prior to this project, 20 adult patients were diagnosed
with depression based on clinical judgment. Follow-up scheduling was performed for zero of the
patient encounters, and no specialty referral for mental health needs was documented for none
of the patients within the 1-month pre-implementation timeframe that was mid-December of
2015 to mid-January of 2016.
Clinical and managerial staff recognized that not only would adult patient outcomes
benefit from the integration of routine depression screening, but such screening would also
assist the clinical staff in quickly identifying and diagnosing those who are clinically depressed.
Overall, this implementation would raise staff awareness of the silent impact of depression on
clinical outcomes, would aid in overcoming the social stigma about open discussion of mental
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health, and would improve patient–clinician rapport. Furthermore, implementation of routine
depression screening in all adult patients, and establishment of appropriate follow-up scheduling
protocols, would comply with the Healthy People 2020 mental health initiatives specific to the
primary care setting.
Purpose of the Evidence-based Practice Project
The purpose of this EBP project was to implement a routine depression screen among
nonpregnant adults at a Midwestern family practice clinic and to establish a follow-up scheduling
protocol to efficaciously manage positively screened patients. The project aims were to increase
the identification of depressed adults in the primary care setting and to enhance current practice
procedures. In so doing, mental health assessment would become a part of daily practice and
would better equip clinicians at this practice to make educated decisions about patient care.
Compelling clinical question
The objective of this EBP project was to answer the compelling clinical question: How
does the use of routine depression screening in conjunction with a follow-up scheduling protocol
assist clinicians with the early identification of and plan of care for depressed patients? This
project included three strategies: (1) implement the 2-item Patient Health Questionnaire (PHQ2) depression screen and follow-up scheduling protocol; (2) change practitioner behaviors
regarding depression screening, follow-up procedures and plan of care; and (3) evaluate the
effectiveness of the EBP project.
PICOT question
The EBP question asked in this project was developed using the PICOT format, which
requires consideration of the essential components of a compelling clinical question. These
components are: the population of interest (P), the issue or intervention of interest (I), the
comparison group (C), the outcome to be measured (O), and the time frame of the intervention
(T) (Melnyk & Fineout-Overholt, 2015). The PICOT question for this project was: “In family
practice, how does the use of a routine depression screening tool (PHQ-2) and follow-up
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scheduling protocol affect the identification and follow-up of patients with depression, compared
to current practice?” Each of these components is defined as follows:
P – The population of interest was adult patients, aged 18 years or older, seen in the
primary care setting. Children and pregnant women were excluded from the project.
Adults were targeted because of the growing concern about the prevalence of
depression and rising suicide rates across the nation (Healthy People 2020).
I – The intervention of interest was integration of the PHQ-2 depression-screening tool
into current patient documentation and implementation of a follow-up scheduling protocol
based on patient responses to the depression screen.
C – The comparison of interest was practice as usual, characterized by a lack of routine
adult depression screening and follow-up scheduling protocol in this general practice
clinic.
O – The primary outcome of interest was to increase the number of accurately identified
depressed adult patients, increase the number of routine depression-screened patients,
and increase practitioner adherence to an evidence-based follow-up scheduling protocol.
T – The EBP project took place from mid-December 2016 to mid-January 2017.
Significance of the EBP project
Due to concern among leading health care institutes about the prevalence of adult
depression in the United States, along with sufficient literature support, this project was
developed to assist in meeting the national objective of routine screening of adults for
depression in the primary care setting. The EBP project manager identified a general practice
site that lacked routine depression screening and consistent follow-up for its general adult
population. These issues made this clinic an excellent setting for project implementation.
The literature supported primary care as the optimal setting for identifying depression
among the general adult population, indicating that depressed individuals are initially seek care
from a general practice setting than from a mental health specialist (Maura, 2016; O’Conner et
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al., 2009). However, the accuracy of identification of depression and the frequency of
depression screening within primary care is subpar, and, as a result, depression and suicide
prevalence continue to increase. Research shows that depression screening alone is ineffective
in adults (O’Connor et al., 2009). However, the effectiveness of routine depression screening
with appropriate follow-up is highly supported in the literature and has been shown to
significantly impact patient health outcomes, resulting in the remission of depressive symptoms
(Arroll et. al., 2010; Corson, Gerrity, & Dobscha, 2004; Fuchs et. al., 2015; Gjerdingen,
McGovern, Miner, & Center, 2009; Kroenke, Spritzer, & Williams, 2003; Löwe, Kroenke, &
Gräfe, 2005; Manea, Gilbody, & McMillian, 2015; Manea et al., 2016; Maurer, 2012;
Nimalasuriya, Compton, & Guillory, 2009; O’Connor et al., 2009; Yackel, McKenna, & FoxDiese, 2010).
Successful implementation of this project would not only benefit clinician–patient rapport,
but would also improve patient outcomes, thus benefiting the community at large. In addition to
the large volume of literature on the consequences of undiagnosed depression, studies
concerning the effectiveness of appropriate follow-up of depressed persons and the benefits of
early identification of depression in primary care practice support this project. The incorporation
of routine depression screening into practice would demonstrate preventative efforts by primary
care practitioners and would show dedication to reaching the goal established by Healthy
People 2020. Implementation of this EBP project followed the national initiative and
recommendations by providing routine support for mental health within the primary care setting.
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CHAPTER 2
THEORETICAL FRAMEWORK, EBP MODEL, AND REVIEW OF LITERATURE
Theoretical Framework
Chapter 2 provides an in-depth analysis of the selected theoretical framework and the
evidence-based practice model and a synthesis of the literature that supports the foundation for
this project. Each of these components was carefully selected for its appropriateness to the
focus of the PICOT question: “In family practice, how does the use of a depression screening
tool and follow-up scheduling protocol affect the identification and follow-up of patients with
depression, compared to current practice?” Each component provides guidance for
implementing the PICOT question into practice. The literature review provides a systematic
analysis of the available evidence and the support necessary to proceed with this EBP project
specific to routine adult depression screening in the primary care setting. John Kotter’s (1996)
Eight Stages of Change (ESC) Model was utilized for the theoretical framework toward changes
in organizational practice, and the Marita Titler’s (2001) Iowa Model of Evidence-Based Practice
to Promote Quality Care (Iowa Model) was applied as the evidence-based practice model.
Overview of Theoretical Framework
Implementation of practice change through initiation of a new scheduling protocol was
expected to be met with some resistance; however, practice changes can provide opportunities
for improvements especially in the realm of preventative healthcare. The key to a successful
organizational change is to help those involved to alter their behaviors (Pollack & Pollack,
2015). The ESC process described by Kotter (1996) offers a step-by-step approach to
behavioral change that leads to successful organizational change; this process is considered
one of the best approaches to systemic transformation (Pollack & Pollack, 2015) and was
chosen as the theoretical framework for this EBP project. The steps included in the ECS
process are to: (1) establish a sense of urgency, (2) create a guiding coalition, (3) develop a
vision and strategy, (4) communicate the vision of change, (5) empower broad-based change,
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(6) generate short-term successes, (7) consolidate achievements and produce more change,
and (8) anchor new approaches in the culture (Pollack & Pollack, 2015). Pollack and Pollack
(2015) recognized that organizational transformations in health care could be achieved by
implementing Kotter’s (1996) linear, 8-step approach.
Application of Theoretical Framework to EBP Project
The first step to Kotter’s (1996) ESC process is the establishment of a sense of urgency.
This step is crucial for obtaining the cooperation of those involved and to achieving
implementation of the desired changes. Examination of the clinical practices used for routine
depression screening at the Midwestern family practice clinic revealed that current practices did
not meet national guidelines and that routine adult mental health screening was nearly absent at
this practice. This observation, in addition to the known negative effects of depression on health
outcomes, indicated the need to implement change, thus fulfilling the sense of urgency. By
alerting the clinical staff to the implications of depression for clinical outcomes (e.g., negative
impacts on pain control and glycemic control, heart disease, chronic lung disease, increased
rates of suicide in older adults), the lack of depression screening created a sense of urgency in
the context of this project.
Step two of the ESC process involves creating a guiding coalition by incorporating
individuals who are involved in the practice change. Since this change took place within an
organization, the guiding coalition was created from various levels of management and clinical
staff. Obtaining support from the chief nursing officer enabled the project to be implemented,
and support from the office manager allowed access to the EBP site. In addition, the clinical site
staffs—one physician, two registered nurses, 2 clerical staff members, and one medical
assistant—were directly involved in the guiding coalition for development of the project.
Step three includes developing a vision and strategy; the project leader must clearly
present the need for change and a plan of action toward the change that involves all members
of the guiding coalition. The first step in a successful strategy for systemic change is to gain the
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support of leading managerial staff. Managerial support was obtained by presenting the need for
change to those at the directorial level and by delineating the benefits of the proposed practice
changes and the vision of the EBP project. The project vision was to routinely screen each adult
(excluding pregnant women) by implementing the PHQ-2 while the patient was in the waiting
room. Depending on his or her summed-item score, the patient could be a candidate for further
evaluation. The project aim was to assist with the Healthy People 2020 goal and combat the
rising suicide rate in the state. The second part of a strategy for system change is to incorporate
the individuals who will be directly impacted by the change; therefore, the EBP project was
proposed to the clinical staff. Engagement with the entire guiding coalition provided important
insights into the dynamic flow between office personnel and into changes that could be feasible
for the practice. This experience offered the opportunity for staff to openly discuss questions
and concerns with the project leader, which resulted in a better understanding of what could be
realistically accomplished by the project.
The fourth step of Kotter’s (1996) ECS process is to communicate the changes that are
expected to occur. Clear communication promotes understanding about the change process
and is a vital component of organizational transformation (Pollack & Pollack, 2015); change will
not occur unless it is supported by those involved. Evidence supporting the practice change was
discussed at meetings with the collaborating physician and nurse practitioners. This forum
reiterated the need to incorporate routine adult depression screening and follow-up scheduling
protocols to meet recommendations for mental health care for all adults receiving services at the
practice. The needs of the guiding collation were delineated and a depression screening followup scheduling protocol that addressed those needs was developed. This follow-up scheduling
protocol included: minimal axillary staff involvement with initial screening; an initial screening
tool that was accurate, of short duration, and easy to score; follow-up for positive screens during
a separate appointment; a diagnostic tool that was evidence-based and easy to use; and
evidence-based treatment options as delineated by the USPSTF (2009) guidelines for
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depressed adults. The project leader emphasized that the vision of the EBP project was to
foster a better understanding of the importance of routine depression screening for adults, the
benefits of early identification, and the significance of swift intervention for those who suffer
silently from depression.
Step five of Kotter’s (1996) process is to remove any factors that could undermine the
project vision (Pollack & Pollack, 2015). To accomplish this, awareness of the office flow and
the potential role and impact of each staff member in the practice change was needed, and
environmental influences needed to be accounted for. This was achieved through open
discussion with the guiding coalition and by observation. The primary environmental influence
on the project was timeliness: practitioners could not afford for the patient check-in process to
be slowed down, and the time allotted per patient encounter could not be increased. Second,
this EBP depression tool needed to be accurate in identifying depressed patients, to avoid
overwhelming the office with additional patient appointments for false-positive screens. Keeping
these limitations in mind, along with collaborative feedback, a realistic process for applying the
screening tool in this clinical environment was developed. Collaboration with the guiding
coalition, and accounting for the realities associated with a busy family practice clinic, led to the
generation of an EBP follow-up scheduling protocol that would not inhibit the office flow and that
would generate positive impacts on practice.
Step six of the ECS is to generate short-term successes, which help to demonstrate the
viability of the practice change and to build momentum for sustainability (Pollack & Pollack,
2015). Kotter (1996) pointed out that short-term wins need to be visible, unambiguously
successful, and clearly related to the direction of change to validate the sacrifice and hard work
of those involved, thus promoting the continuation of efforts toward the desired outcome
(Pollack & Pollack, 2015). Daily data collected, such as the number of positive depression
screens, the number of follow-up appointments made, and the severity of depression at followup, was shared with the guiding coalition. Such updates provided insight into the need for
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follow-up scheduling protocol adoption and into the progress of implementing the practice
change. Data collection provides an overview of the mental health of the local community, and
data from follow-up appointments provides insight into the impact of the practice change on the
patient community. Short-term successes promote the cooperation and participation of involved
staff, thus increasing momentum toward a successful practice change.
In step seven, the consolidation of gains produces additional change. In this step, all
data and achievements at the end of the project implementation period are accounted for. By
consolidating the data, results are translated into a narrative that describes the overall effect of
the changes in practice. The results of the EBP project reveal whether there are future barriers
to be overcome or whether adaptations need to be made to the follow-up scheduling protocol,
thus producing more change.
Finally, the eighth step of Kotter’s (1996) ESC process is to anchor new approaches in
the culture. Anchoring ensures the sustainability of the implemented change; the new practices
must be enmeshed into the culture of the organization. The practice change—routine
depression screening with a follow-up scheduling protocol—was a new approach for the project
site, and implementation of this approach aimed to create a new culture by introducing mental
health assessment prior to each patient encounter. Through this process, patients would
become more accustomed to mental health assessment, and clinicians would incorporate
routine depression assessments, without much extra effort by either party. If each of the
previous steps of the ESC process were successfully completed, routine depression screening
and utilization of the follow-up scheduling protocol would become standard practice for the
organization, and the EBP project could be considered both successful and viable.
Strengths and Limitations of Theoretical Framework for EBP Project
The strengths of the ESC as a theoretical framework for this EBP project included a
clear linear process for implementing an organizational change. Limitations to the ESC process
included that the process and steps described above might have required revisiting through
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multiple iterations according to the underlying factors encountered. In addition, the ESC process
depended largely on the input of the guiding coalition, which moved through the stages of the
process at varying speeds depending on the stakeholder.
Evidence-based Practice Model
In general, EBP describes a model of care guided by research-based evidence, clinical
expertise, and patient preferences (Schmidt & Brown, 2015). By combining these elements, use
of the EBP improves the quality of patient care. EBP emphasizes a continually striving to reach
the highest quality of care by elevating clinical practice. However, changes in practice required
by this process can be unwelcome in the clinical setting.
Evidence-base practice models assist in the translation of evidence into clinical practice
and require a systematic approach to navigate the multiple interconnected systems that make
up a healthcare organization. An EBP model can serve as a guide for those who are reluctant to
change, and these models facilitate the translation of research-based evidence into clinical
practice in a timely manner. For these reasons, the use of a model specific to organizationallevel-based practice changes—the EBP Iowa Model—was chosen for this project to implement
a practice change within a health care organization.
Overview of EBP Model
The Iowa Model of Evidence-Based Practice to Promote Quality Care (Iowa Model) was
first developed by Marita Titler, Director of Nursing Research, Quality, and Outcomes
Management at Iowa University. The Iowa Model illustrates how acquired knowledge can guide
the implementation of practice change (Titler et al., 2001). The Iowa Model takes into account
the impacts of practice change on the overall health care system and includes steps to help
facilitate practitioner engagement in identifying problems and developing solutions to translate
evidence into clinical practice. The 3 steps in the Iowa Model that guide EBP practice change in
an organization are to: (1) identify a problem-focused or knowledge-focused trigger that initiates
the need for change and that indicates the degree to which the change is a priority for the
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organization, (2) review and critique the available literature, and (3) identify research evidence
that supports the change in clinical practice (Tilter et al., 2001).
Application of EBP Model to EBP Project
Titler and colleagues (2001) defined a problem-focused trigger as a clinically based
problem or a risk-management issue, whereas a knowledge-focused trigger is based on new
research evidence or a new practice guideline. This EBP project was initiated by a problemfocused trigger: mental health assessment was not being considered routinely with patient
exams as encouraged by USPSTF (2009) guidelines. Agreement between clinicians that mental
health assessment was subpar elevated the need for practice change to high priority in order to
provide the highest quality care. The collaborating physician at the project site formed a team
with the EBP project leader to develop a depression follow-up scheduling protocol. This followup scheduling protocol would also be evidence-based and dependent on findings from the
literature review.
Review and critique of the relevant literature (step 2 of the Iowa Model; Titler et al.,
2001) should indicate whether there is sufficient evidence to warrant a clinical practice change.
For this project, 13 high-quality evidence-based articles were assembled that provided sufficient
evidence for the need for change. The collection of evidence and the critique process are
explained in detail in the Literature Search section of this paper.
After a need for practice change is documented, the project leader can pilot the change
by (1) selecting the outcomes to be achieved, (2) collecting baseline data, (3) designing EBP
guidelines, (4) implementing EBP at the pilot site, (5) evaluating the process and outcomes, and
(6) modifying the practice guidelines.
To achieve the selected outcomes, the project leader and team determined the number
of patients to be identified in the initial screen, the number of follow-ups needed, the number of
patients diagnosed with depression at follow-up, and the type of follow-up chosen by the
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practitioner. They then surveyed the practitioners’ awareness of depression before and after the
practice change.
Baseline data collection included the number of patients diagnosed with depressive
symptoms at the EBP site during the same 1-month time period one year earlier, through a
survey of ICD-10 codes. In addition, a pre-EBP-project survey about practitioners’ use of the
PHQ-9 depression screen for diagnosis, awareness of symptoms and effects of depression was
conducted.
The pilot change in practice was the design of the EBP guidelines, which were agreed
upon by the collaborating physician and was guided by relevant, high-quality evidence from the
literature. The change to practice included initiation of an EBP depression-screening tool at
patient check-in (in the waiting room); evidence supported the use of the PHQ-2 as an initial
screen. A positive cut-off score ≥3 on the PHQ-2 warranted immediate additional assessment of
the severity of depression symptoms by implementing the 9-item Patient Health Questionnaire
(PHQ-9). A cut-off score ≥10 on the PHQ-9 indicated major depression; in these cases, followup scheduling protocol included: treatment followed “usual practice” delineated by the USPSTF
(2009) clinical guidelines along with scheduling a follow-up appointment per the practitioner’s
discretion for depressed adults.
Implementation of this EBP project occurred after Institutional Review Board (IRB)
approval was obtained from Valparaiso University and the affiliated project site and took place
from mid-December 2016 to mid-January 2017. The pilot unit was a busy Midwestern family
practice clinic that housed three physicians and two nurse practitioners. The patients that were
recruited were associated with one collaborating physician and one nurse practitioner.
The EBP project leader managed and evaluated the project implementation process.
Daily evaluation involved collecting PHQ-2 screens from participating practitioners to monitor
that initial screening was being completed. Each initial screen was scored and need for
additional screening was determined and distributed by the project leader, and a subsequent

ROUTINE PHQ-2 DEPRESSION SCREEN

18

appointment was established at checkout with patients that required further evaluation. If the
patient did not schedule a follow-up appointment or did not show up for a follow-up appointment,
the clinical staff would attempt to contact the patient by phone on two separate occasions during
the week of the initial screening or the day of the follow-up appointment. In addition, if the
patient could not be reached to establish a follow-up appointment, failure to establish follow-up
was documented in the patient chart and the practitioner was notified. Patient follow-up was
managed, and the numbers of follow-ups and refusals were documented, with notification of the
practitioner when necessary. Finally, the practitioner’s charts were reviewed to monitor
utilization of the PHQ-9, severity of the diagnoses, and treatment choices.
The project leader was responsible for considering modification of practice guidelines
during the pilot change in practice. This step took place weekly through face-to-face feedback
from participating clinician. Open communication within the team was maintained to facilitate
necessary changes and to address immediate concerns.
The third step of the Iowa Model is to determine whether it is appropriate to adopt the
pilot change into practice (Titler et al., 2001). Adoption of the pilot change is dependent on the
accumulated short-term success and resulting descriptive data. The pilot change would be
considered successful based on an increase in the number of depressed patients identified per
the PHQ-2 screen, along with an increase in the frequency of follow-ups appointments
completed by the practitioner. If the EBP project was successful, the project findings could be
disseminated with the aim of inspiring changes in practice at other health care facilities.
Strengths and Limitations of EBP Model for EBP Project
The Iowa Model is commonly used to implement organization-based practice changes. A
major strength of the model is that it provides a systematic approach to translating EBP
evidence into a pilot change in practice. Multiple feedback and evaluation loops enable critical
monitoring of the clinician at the each step of EBP process. The model allows evidence to be
tailored to the practice setting, and it supports an interdisciplinary team approach, which is
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realistic and appropriate for health care settings and organization-based change. Finally, the
model follows a basic problem-solving approach structured after the scientific process, which
makes it highly compatible with the realm of health care.
There are some limitations to the Iowa Model, which include several feedback loops that
evaluate model implementation at various stages of the development process that can result in
multiple modifications (Melnyk & Fineout-Overholt, 2015). Each step of the Iowa Model is critical
to customizing evidence that is relevant to the practice setting and to promoting adoption within
the health care system. Although the model is not linear in structure, it highlights the realistic
and complex process of implementing an EBP practice change in an organization.
Literature Search
A review of the relevant literature was performed after the PICOT question was
articulated, as the second step of the Iowa Model (Titler et al., 2001). The process, results, and
appraisal of the literature search are detailed in the following sections.
Sources Examined for Relevant Evidence
The literature search was initially conducted using electronic databases, followed by a
manual search of relevant references. Four electronic databases were searched: the Cochrane
Collaboration and Library, the Cumulative Index to Nursing and Allied Health Literature
(CINAHL), the Joanna Briggs Institute Clinical Online Network of Evidence for Care and
Therapeutics (JBI ConNect), and MEDLINE via EBSCO. Titles and abstracts were reviewed to
ensure that the resulting literature was appropriate for the PICOT question. After the relevancy
criteria were established, the selected abstracts were reviewed for potential use. The reference
list of each included article was also searched for usable evidence.
Inclusion and Exclusion Criteria. Search results were narrowed to a manageable
number using inclusion and exclusion criteria. For an article to be included in the literature
review, it had to: a) be peer reviewed; b) be based on research; c) be published in English; d)
be specific to adult (18+ years old) patients; e) involve a primary health care setting; f) culturally
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comparable to the U.S. population; g) be published in 2002 or later. Articles were limited to 2002
and after because the original USPSTF depression screening guideline was published in 2002
and added to in 2009. Articles were excluded from the literature review if they: a) were not
focused on a primary health care setting; b) focused on mental health disorders other than
depression; c) focused on children and adolescents; d) focused on pharmaceutical or surgical
treatment; e) were not available in English; f) included pregnant women, children, or
adolescents in the sample population; g) examined a population that was not culturally
compatible to the American population; or h) were published prior to 2002.
CINAHL and MEDLINE Results. Titles and abstracts in CINAHL and MEDLINE were
searched using the keywords PHQ-2, PHQ-9, “adult,” “depression,” “screen” and “follow-up”
combined by the Boolean operator “AND” under the mesh heading “Primary Health Care.” Five
relevant articles that met the inclusion and exclusion criteria were retrieved from CINAHL; 12
relevant articles were retrieved from MEDLINE, but only five of these were deemed appropriate
for the review. Four articles were excluded because the focus populations were in small African
countries and thus were not comparable to the American population, two articles were
duplicates from the CINHAL search, and one article was excluded because it dealt with an
adolescent sample group. The full text of each article was acquired and critiqued as delineated
in the Construction of Evidence-based Practice.
Cochrane Library and JBI Results. Titles and abstracts in the Cochrane Library and
JBI databases were searched using the keywords: “primary care,” “depression” and “screen*”
combined by the Boolean operator AND. Three relevant articles populated from the Cochrane
Library database, but none were deemed appropriate for further review; two were excluded
because they focused on adolescent populations, and one was excluded because the tool of
interest was not considered in the article. The JBI search returned 50 articles, but none were
considered relevant for this EBP review, as most addressed specialty populations such as those
with dementia or anxiety.
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A manual search of the reference list of each of the 10 selected articles was performed
to identify additional relevant material, and two additional articles were found. The full text of
those articles was acquired and critiqued for level and quality of evidence. The following
websites were used to reference clinical guidelines: National Institutes of Health, Indiana State
Department of Health, Healthy People 2020, U.S. Preventative Services Task Forces, American
Association of Family Physicians, and Veterans Administration. Clinical guidelines were
collected from these organizations and cross-referenced for development of the EBP project. A
manual search of additional materials was conducted for each website. One clinical guideline for
depression screening of adults was used for the project, collected from the USPSTF (2009),
along with clinical practice recommendations from the American Association of Family
Physicians, the American College of Physicians, and the American College of Preventive
Medicine. A summary of keywords and database searches is presented in Table 2.1.

Table 2.1
Summary of Search Terms & Databases
Database

Search terms

Date Range

Limiters

CINAHL

MeSH: “Primary
Health Care” AND
“depress*” AND
“screen*” AND
“PHQ-2” OR
“PHQ-9”

2002–2016

Not Pregnant
Peer Reviewed
Published in English and after
2002Comparable to U.S.

MEDLINE

MeSH: “Primary
Health Care” AND
“depress*”
AND “screen*”
AND “PHQ-2” OR
“PHQ-9”

2002–2016

Cochrane

“Depression” AND
“Screen”
“Depression
screen”

JBI

Manual Search Not applicable
Total

Results

Relevant

Replica
Articles
0

Articles
Used
5

16

5

Not Pregnant
Peer Reviewed
Published in English and after
2002Comparable to U.S.
population ≥18 years old
PHQ-2 or 9

46

12

2

5

2002-2016

Not Applicable

3

1

0

0

2002-2016

Not Applicable

7

0

0

0

2002-2016

Not Applicable

50

11

5

3

population≥18 years old
PHQ-2 or 9

13
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Levels of Evidence
Melnyk and Fineout-Overholt’s (2015) rating system for the hierarchy of evidence was
used to determine the level of evidence for each article obtained from the literature review. This
system considers the following seven levels of evidence. Level I: findings obtained from a
clinical guideline, systematic review, or meta-analysis of relevant randomized controlled trials
(RCTs); level II: evidence from well-designed RCTs; level III: evidence obtained from controlled
trials without randomization; level IV: evidence from a well-designed case-control or cohort
study; level V: evidence gathered from systematic reviews of descriptive and qualitative studies;
level VI: evidence obtained from single descriptive or qualitative studies; level VII: evidence
based on the opinion of authorities and/or reports of expert committees. The initial searches
returned 122 potential articles, 13 of which were deemed appropriate for this project based on
the evidence they contained (Table 2.2).
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Table 2.2
Summary of Level of Evidence by Article
Author(s)
Type of Study
Arroll et al., 2010
RCT
Corson et al., 2004
RCT
Fuchs et al., 2014
Cohort
Gjerdingen et al., 2009
RCT
Kroenke et al., 2003
RCT
Lowe et al., 2005
Cross-sectional cohort
Manea et al., 2014
Meta-analysis
Manea et al., 2016
Meta-analysis
Maurer, 2012
AAFP expert opinion
Nimalasuryia et al., 2009
Expert opinion
O’Connor et al., 2009
SR
USPSTF, 2009
Clinical guideline
Yacket et al., 2010
Pilot project
Adapted from: Melnyk & Fineout-Overholt (2015)
RCT = randomized control trial.
SR = systemic review

24

Level of Evidence
II
II
IV
II
II
IV
I
I
VIII
VII
I
I
III
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Appraisal of Relevant Evidence
Evidence was appraised for quality using the Critical Appraisal Skills Program (CASP)
completeness of criteria (CASP, 2013). The CASP approach to literature appraisal is a threestep process guided by a checklist that is unique to each study design. This approach assesses
the validity of the study, the reliability of the results, and the applicability of the findings. The
CASP checklists provide a transparent way to determine a study’s quality of evidence without
bias. The quality of each article was assessed based on the completeness of the CASP (2013)
criteria, and quality scores were assigned based on Melnyk and Fineout-Overholt’s (2015)
ranking system.
Evidence quality scores for all articles were derived from the study’s ability to satisfy the
CASP criteria. If a study fulfilled the three requirements of validity, reliability, and applicability, it
was considered to provide good quality evidence (Melnyk & Fineout-Overholt, 2015) and
received the highest quality ranking. If the study fulfilled two of the CASP criteria, it received a
fair ranking, and if only one or none of the CASP requirements was met, the study received the
lowest ranking and was considered of poor quality (Melnyk & Fineout-Overholt, 2015).
Quality scores were determined for one clinical guideline, two systematic reviews, two
meta-analyses, six RCTs, one cohort study, one cross-sectional study, one pilot study, and two
expert opinion pieces; a total of 13 articles were reviewed for quality and level of evidence
relevant to this EBP project. The clinical guideline (USPSTF, 2009), systematic reviews
(O’Connor et al., 2009), meta-analyses (Manea et al., 2014; Manea et al., 2016), and RCTs
(Arroll et al., 2010; Corson et al., 2004; Gjerdingen et al., 2009; Kroenke et al., 2003) fulfilled
each CASP criterion, receiving a good quality score. The clinical guidelines included information
on the developers, stakeholders, and best-practice recommendations with accompanying
research data, generalizability, and findings from related sources. Each systematic review
clearly delineated the quality of research behind each recommendation, provided a good
description of data collection methods, reported all results, and discussed any results that were
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significant for practitioner knowledge. The RCTs fulfilled all CASP criteria by clearly reporting
methods of sample recruitment, intervention methods, data collection and synthesis,
generalizability, study limitations, and future research directions. The cohort study (Fuchs et al.,
2014), cross-sectional study (Lowe et al., 2005), and pilot study (Yackel et al., 2010) received
fair quality-of-evidence scores. Although these studies clearly delineated the methods used for
sample recruitment, intervention, and data synthesis, they did not adequately discuss
confounding factors, and sample effects were minimal due to the small sample size. Lastly, the
expert opinion article (Maurer, 2012; Nimalasuryia et al., 2009) received a poor quality score.
This article clearly discussed the relevance of peer-reviewed results behind recommendations
for clinical practice, along with the direct relationship of the results to patient care and feasibility
of integration into practice. However, the article did not discuss the efficacy or application of the
recommended results, which prevented conclusions from being drawn about the reliability and
validity of the recommendations (Melnyk & Fineout-Overholt, 2015).
Construction of Evidence-based Practice
The evidence selected was drawn primarily from studies with quantitatively focused
designs. The majority of the data was derived from systematic reviews and randomized control
trials, which was more conducive to formulating EBP recommendations compared to qualitative
evidence. The following section reviews each selected article and summarizes the level of
evidence assigned, the population studied, and the methods, interventions, and results. A
summary of the literature review is provided in the Summary of Evidence Table (see Appendix
A)
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Arroll et al. (2010)
The aim of Arroll et al. (2010), who used an RCT, was to determine the relative benefits
of the initial use of the PHQ-2 and the PHQ-9 for depression screening in comparison to the
computerized Composite International Diagnostic Interview (CIDI) as a reference standard, in
the primary care setting. This study acknowledged the work of Kroenke et al. (2003), which
validated the PHQ-2 for initial depression screening in adults. In addition, Arroll et al. (2010)
investigated the yields obtained by the PHQ-2 and PHQ-9 at a range of thresholds and
compared each threshold score to the original scoring systems described by Spritzer et al.
(1999). Major depression was first quantified and measured by the Spritzer scoring system, as a
summed-item score of ≥2 on at least one of the first two questions and a minimum score of ≥2
on the five screening questions included in the original PHQ.
This study was conducted according to the Standards for the Reporting of Diagnostic
Accuracy Studies (STARD) guidelines. Prior to their implementation, the study methods and
procedures used were approved by Northern Regional Ethics Committee, Ministry of Health
(ethics approval number NTY/06/09/080).
Participant recruitment took place from the convenient sample of patients in the waiting
room, and patients were recruited consecutively to obtain an adequate spectrum of disease. All
eligible patients gave informed consent prior to enrollment in the study. The inclusion criteria
included: age 16 or older, English speaking, and no history of brain injury, dementia, terminal
illness, or history of substance abuse. A limitation of this recruiting process was that it did not
eliminate those who were taking psychotropic medications. Upon consenting to the study,
participants were placed in a private room and randomly assigned either the PHQ-2 or the PHQ9 screen, after which they completed the CIDI as a reference standard. All results were coded
and sealed in opaque envelopes to ensure privacy. The research assistant was blind to the
screen assignment and results of the CIDI. After completing the initial screening and CIDI,
patients saw their physician, who read their results and indicated whether the patient had
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depression and, if so, the level of severity. A total of 7,757 primary care patients participated in
this study.
All statistical analyses were calculated by the Centre for Evidence-Based Medicine
calculator on the University of Toronto website. Sensitivity and specificity were calculated for
each screen and compared to the reference standard. The CIDI data indicated that within the
past month, major depression occurred in 6.2% of the study sample. The PHQ-2 results at a
threshold score of ≥2 indicated a sensitivity of 0.86, meaning that 86% of those with major
depression were positively identified. The specificity of the PHQ-2 was 0.78, meaning that 22%
(1 – 0.78) of those who did not have depression had a positive score (i.e., the screen returned a
false-positive result). The negative predictive value (representing false-negative screens) for the
PHQ-2 was 1.2% of the sample. Among those who were screened by the PHQ-9, sensitivity
was 0.74 and specificity was 0.91 at a threshold score of ≥10. The negative predictive value for
the PHQ-9 was 1.8, slightly higher than for the PHQ-2. In comparison, the proportion of PHQ-2
participants with scores ≥2 that needed to be further evaluated by the PHQ-9 was 26%.
However, when the PHQ-2 threshold score was increased to ≥3, the specificity of the test
increased significantly to 0.92 and only 11% of participants needed further assessment by the
PHQ-9 screen.
Over all, this study determined that initial assessment of adult depression in a primary
care setting by PHQ-2 was accurate and sensitive for identifying major depression compared to
the reference standard. An inverse relationship was found between sensitivity and specificity for
both screens; as sensitivity increased, specificity decreased. From these results, and because
of the significant decrease in false negatives at scores ≥3, a threshold score of 3 or higher for
the PHQ-2 was determined to be the most effective for accurately identifying depression. Use of
the PHQ-9 with a threshold score of ≥10 was more successful at detecting major depression
compared to the original Spritzer scoring system, suggesting that the original Spritzer scoring
methods were too strict for clinical practice.
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Implications for practice supported application of the PHQ-2 with a threshold score of ≥2
or 3 as an initial depression screen for adults in the primary care setting, followed by the PHQ-9
for all positives. The score cut-off is at the discretion of the clinician; a lower score may include
a larger group of false positives. The PHQ-2 was found to be a useful and time-saving tool in
assisting primary care clinicians with screening for depression. The PHQ-9 with a threshold of
≥10 was validated as an accurate diagnostic for major depression and level of severity and
should follow any positive PHQ-2 screen.
Corson, Gerrity, and Dobscha (2004)
Corson, Gerrity, and Dobscha (2004) evaluated the psychometric properties for
depression screening by comparing the PHQ-2 to the PHQ-9 in a Department of Veterans
Affairs primary care setting. A total of 1,211 patients were randomized between the PHQ-2
screen (n = 497) and the usual care PHQ-9 screen (n = 714). The study found that the PHQ-2,
with a cut-off score of ≥3, had higher sensitivity (97%) and specificity (91%) for identifying
depression compared to the standard PHQ-9 (sensitivity and specificity of 88%). Similar to other
studies, Corson et al. (2004) found an increased risk of false positives when the threshold for
the PHQ-2 screen was <3. Therefore, those who scored ≥3 should be evaluated for severity of
depressive symptoms by the PHQ-9. Overall, the findings of Corson et al. (2004) complement
those of Kroenke et al. (2003), in that the PHQ-2 offered a rapid and accurate assessment of
psychometric properties for depression screening in adults. This study recommended use of the
PHQ-2 with a score ≥3 for routine depression screening in the primary care setting. In addition,
this study recommended that those identified as depressed be further evaluated with the PHQ-9
to clarify the severity of depressive symptoms and to determine the most appropriate plan of
care.
Fuchs et al. (2014)
In a retrospective cohort study, Fuchs et al. (2014), examined barriers associated with
implementation of the PHQ-2 as an initial depression screen with follow-up diagnostics by the
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PHQ-9 in the family practice setting. The study described the actions taken by family
practitioners following a positive PHQ-2 screen, the environmental factors that influenced their
use of the PHQ-2 and PHQ-9, and the impact of the test scores on treatment decisions. In this
two-part study, a retrospective chart review of patient medical records was performed over a 1month period to describe frequency of depression screening with the PHQ-2, the prevalence of
follow-up by PHQ-9 diagnostics, and actions taken by clinicians when a positive PHQ-2 screen
occurred. Then, a qualitative survey of the clinicians was performed to assess the extent to
which the PHQ-2 and PHQ-9 results guided plan-of-care and treatment decisions for depressed
patients. This study included 55 physicians, 39 residents and 16 senior faculty physicians
affiliated with a university hospital-based family medical clinic that served a large, diverse
patient population. Before initiation of this study, all patients routinely received the PHQ-2 prior
to their appointments, and a score of ≥2 was considered a positive indicator of depression, for
which follow-up with the PHQ-9 was recommended. However, administration of the follow-up
was at the physician’s discretion.
Evaluation of physicians’ depression assessments was performed from randomly
chosen patient charts in the 1-month retrospective chart review. Data extracted from these
charts included number of patients with a positive PHQ-2, frequency of follow-up by PHQ-9, and
treatment modality for depression. During the review 1,744 charts noted patients having
completed the PHQ-2, and 412 charts indicated a positive screen. From the charts with positive
PHQ-2 screens, 200 were randomly selected using a Microsoft Excel random number generator
and were reviewed for follow-up and treatment; only 5% (n = 10) of these charts indicated that
patients had received the PHQ-9 screen as follow-up. Of those who received the PHQ-9, the
mean score was 19.30 (SD = 7.03), indicating moderate to severe depression. Eleven of the
charts indicated newly identified depression, and only four of these patients received the PHQ-9
for diagnostic screening. Among the 200 charts with positive PHQ-2 scores, 21% of patients
had visited the clinic for a mental health complaint. Regarding medication management, 49.5%
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of charts with positive PHQ-2 screens continued current medication (no changes made), 19%
initiated new medication, 12% discontinued medication, 9% increased medication, 3% resumed
previous medication, and 2% decreased medication. Only eighteen patients (9%) were referred
to a mental health specialist, and the majority of patients with a mental health complaint were
prescribed an antidepressant (>77.8%). Of the 200 charts audited, 16.5% of patients (n = 33)
returned the following month for another office visit, mostly due to changes in medication at the
index visit (64%). The chart audits indicated that 66% of patients who had a medication change
at the index visit still had a positive PHQ-2 score at the 1-month follow-up.
In the second portion of this study, 26 of the 55 physicians participated in an anonymous
survey about depression screening and management. No physicians “always” reviewed PHQ-2
scores, 11% indicated that they “almost always” reviewed the scores, 39% reviewed scores for
“most visits,” 27% “sometimes” reviewed scores, and 19% “rarely” reviewed the PHQ-2 results.
The most common reason for not reviewing the PHQ-2 score was because the patient already
had a documented depression status (77%). Other reasons included forgetting (70%) or other
concerns taking precedence during the visit (39%). Reasons given for not discussing positive
PHQ-2 scores included time constraints (62%) and other concerns taking priority during the
patient visit (57%). Only 4% of physicians indicated doubts about the utility of PHQ-2 scoring.
Regarding depression management, most physicians reported using clinical judgment
“most of the time” to “almost always” in relation to a mental health referral (96%) or to initiate or
change medication (85%). In contrast, only 35% of physicians indicated that they utilized the
PHQ-9 “most of the time” or “almost always” to assist in decisions about referral or medication.
When physicians were surveyed about their confidence in treating depression with medication,
on a scale ranging from “strongly disagree” (–2) to “strongly agree” (2), the majority expressed
below-average confidence (M = 1.33; SD = 0.68). In addition, the majority of physicians
surveyed treated depression mostly by medication (81%). The most common reasons for not
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treating depressed patients with medication were patient preference (62%), adverse effects
(46%), and medication interactions (46%).
In summary, this retrospective chart review revealed that when left to the discretion of
the physician, follow-up of positive PHQ-2 screens with the recommended PHQ-9 screen rarely
occurred, which demonstrated the importance of standardizing depression screening in clinical
practice. The absence of follow-up for positive PHQ-2 screens was primarily due to time
constraints and competing demands during the patient visit. This study supported the further
assessment of all positive PHQ-2 screens by application of the PHQ-9 at a follow-up
appointment. The addition of a follow-up appointment specific to addressing a positive index
screen overcomes the obstacles of time restrictions at the initial appointment, allowing for
clinicians to focus only on the mental health assessment, and assist physicians in making more
educated clinical decisions about depression management and treatment. Overall, a separate
appointment for depression evaluation improves the quality of care regarding mental health
management.
Gjerdingen, Crow, McGovern, Miner, and Center (2009)
A randomized control trial conducted by Gjerdingen, Crow, McGovern, Miner, and
Center (2009) validated use of the PHQ-2 and PHQ-9 screens for postpartum depression
monitoring and showed the feasibility of screening for postpartum depression during well-child
visits in family medicine and pediatric clinics. The overall purpose of this RCT was to assess the
impact of routine screening for postpartum depression. Seven clinics participated in the study,
including 4 family practice and 3 pediatric clinics. Patient eligibility included mothers who were
12 years of age or older, who were English literate, and who had a 0- to 1-month-old infant
receiving care at a participating clinic. A total of 506 mothers participated in the study. The
Structured Clinical Interview for DSM-IV (SCID) was used as the reference standard for
identification of depression. All participants were initially screened at the 0- to 1-month well-child
visit by a doctoral-level psychology student who was trained in SCID interviewing; participants
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were also given the PHQ-2 and PHQ-9 screens. Following the initial screen, mothers randomly
received the PHQ-2 or PHQ-9 at each well-child visit (at 2, 4, 6, and 9 months), and if a new
onset of depression was identified the mother would return within 2 weeks for a SCID interview.
Major depression was indicated by a threshold score of 2 for the PHQ-2, and a threshold score
of 10 was used for the PHQ-9 screen.
Over the course of the study, 45 (8.9%) of postpartum women were identified as having
major depression. At the 0- to 1-month initial well-child visits, the SCID interview identified 20
mothers (4.6%) as depressed. Validity results for the summed-item scoring of PHQ-2 screens at
the initial visit had a sensitivity of 75%, specificity of 88%, positive predictive value of 24%, and
negative predicative value of 99%. The PHQ-9 had a sensitivity of 75%, specificity of 91%,
positive predicative value of 28%, and negative predicative value of 99%. The similar results for
the PHQ-2 and PHQ-9 validated the use of either test as an initial screen for post-partum
depression.
Over the entire study, the PHQ-2 had a sensitivity of 84%, specificity of 79%, positive
predicative value of 28%, and negative predictive value of 98%; the PHQ-9 had a sensitivity of
82%, specificity of 84%, positive predictive value of 33%, and negative predicative value of
98%.
Women were more likely to complete their screens at pediatric clinics than at family
medicine clinics (46.3% vs. 27.2%, P = 0.000). Gjerdingen et al. (2009) attributed this significant
difference to the introduction of electronic medical records at the family medicine clinics, which
created a barrier to the preparation of patient charts prior to the clinic visit.
Over all, the study found that routine postpartum depression monitoring by PHQ-2 or
PHQ-9 was highly feasible in a pediatric clinical setting. The PHQ-2 with a threshold score of 2
was validated as an accurate initial screen for identifying postpartum depression, and the PHQ9 was validated for use as a diagnostic follow-up. A limitation of the study was that it did not
analyze higher threshold scores for the PHQ-2 because it followed the initial recommendations
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of Kroenke, Spitzer, and Williams (2003). The strength of the study was its demonstration of the
longitudinal applicability of the PHQ-2 or PHQ-9 for postpartum depression screening.
Kroenke, Spitzer, and Williams (2003)
Kroenke, Spitzer, and Williams (2003) conducted a large randomized control trial to
assess the criteria and construct validity of the PHQ-2 screen for identifying depression
compared to the PHQ-9 screen as the reference standard. A total of 6,000 adult patients from 8
primary care and 7 obstetrics–gynecology clinics participated in the study. Sample bias was
minimized by sampling either consecutive patients for a given clinic session or every nth patient
until the sample size quota was achieved. Prior to visiting with the physician, all patients
completed the PHQ-9. In addition, the diagnostic status of 580 patients was assessed by
structured psychiatric interviews with an independent mental health professional that was blind
to the PHQ-9 results. Construct validity of the PHQ-2 was assessed by examining patient’s
functional status, disability days, symptom-related difficulty, and the number of clinic visits
across a range of PHQ-2 scores. Analysis of covariance was used with PHQ-2 score as the
independent variable and was adjusted for age, gender, race, education, study site, and number
of physical disorders. The Bonferroni correction was used to adjust for multiple comparisons.
The control group included subjects that maintained a PHQ-2 score of zero.
The study found that the majority of patients with no depressive disorder had a PHQ-2
score of <3 (95%), whereas the majority of those with depressive disorder had a PHQ-2 score
≥3 (83%). Among the 580 patients, sensitivity for major depressive disorder at a cut-off score of
≥2 was 92.7%, specificity was 73.7%, positive predictive value was 21.1, and the likelihood ratio
was 0.6. Use of the PHQ-2 with a positive threshold score of ≥3 had better specificity (90.0%),
slightly lower sensitivity (82.9), and better positive predictive value (38.8) and likelihood ratio
(2.9). As the threshold PHQ-2 score increased to a maximum of 6, the sensitivity of the screen
decreased, but the specificity, positive predictive value, and likelihood ratio increased
significantly, much like the findings of Arroll et al. (2010). Furthermore, at a cut-off of ≥3, the
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likelihood ratio for major depression was nearly identical to the overall likelihood ratio reported in
the meta-analysis of 9 case findings conducted by Mulrow, Williams, and Gerety (1995). The
use of PHQ-2 with cut-off ≥3 was comparable to the PHQ-9 diagnostic algorithm per the mental
health professional interview for major depression (kappa values of 0.48 and 0.54) and for any
depressive disorder (kappa values of 0.62 and 0.58). PHQ-2 scores were most strongly
correlated with perceptions of mental health (kappa values of 0.70 and 0.63) and general health
(0.47 and 0.46), and they were least correlated with bodily pain (0.26 and 0.31). Greater
severity of depression was significantly associated with increased disability days, frequency of
clinic visitation, and symptom-related difficulties.
Over all, this study strongly validated the PHQ-2 as a brief depression screening
measure. A strong association (P < 0.05) between PHQ-2 scores and functional status,
disability days and symptom-related difficulties demonstrated the validity of the criteria. The
results were similar among patient populations and across all 6,000 participants, which
enhanced the generalizability of the findings. This study recommended use of the PHQ-2 as the
initial step to identifying depression among adults, with a threshold score ≥3 to provide the best
compromise between sensitivity and specificity, and it proposed that all positive PHQ-2 screens
should be further investigated with the PHQ-9 to diagnose the severity of depression.
Löwe, Kroenke, and Gräfe (2005)
A cross-sectional and longitudinal cohort study conducted by Löwe, Kroenke, and Gräfe
(2005) investigated the psychometric characteristics of the PHQ-2 as a brief measure for
diagnosing depression and for follow-up monitoring over one year. Löwe et al. (2005) evaluated
the reliability, construct and criterion validity, and sensitivity to change of the PHQ-2 screen
compared to the SCID as the reference standard and to the following lengthier depression
screens: the PHQ-9, the Hospital Anxiety and Depression Scale (HADS), the World Health
Organization Five-Item Well-Being Scale Index (WBI-5), and the Twelve-Item Short Form Health
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Survey (SF-12). The four SCID administrators were blind to all questionnaire results. Informed
consent was obtained from all patients at baseline and, when applicable, at follow-up.
The cross-sectional study was performed in seven outpatient and family practice clinics,
from which 1,619 adult patients were recruited. All recruited patients completed the PHQ-2,
PHQ-9, HADS, WBI-5, and SF-12. From the 1,619 participants, every third patient was invited to
participate in the SCID interview on the day of their appointment or within one week, resulting in
recruitment of 520 patients. The participation rate for the cross-sectional portion of the study
was 88%.
At baseline, SCID diagnosed 71 participants (13.6%) with major depressive disorder and
132 (25.4%) with any depressive disorder. Of the 520 patients in the longitudinal follow-up, 55
individuals were diagnosed with major depressive disorder at baseline and 53 with any
depressive disorder.
Convergent validity was assessed for the total sample population and was measured as
Pearson’s intercorrelation between the PHQ-2 and each of the additional questionnaires.
Convergent validity of the PHQ-2 was measured by Pearson’s intercorrelation, which
demonstrated substantial correlation between the PHQ-2 and other depression-related
measures. These correlations indicated that work disability increased significantly from no
depression (23.7%) to other depressive disorders (35.9%) to major depressive disorder (61.8%)
(X2 = 19.5, DF = 2, P = 0.001). The prevalence of work disability was 9.9% in those with a PHQ2 score of 1 and significantly increased to 52.5% as the score for the PHQ-2 reached a
maximum of 6 (P < 0.001).
Cut-off scores for the PHQ-2 for major depressive disorder or any depressive disorder
were demonstrated by a maximum Youden index. At a threshold score ≥3, the PHQ-2 showed
the best trade-off between sensitivity (87%) and specificity (78%) for major depressive disorder
and between sensitivity (79%) and specificity (86%) for any depressive disorder. These results
are echoed by the findings of Manea et al. (2016). Over all, diagnostic accuracy of the PHQ-2 at
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a cut-off score ≥3 was measured as the area under the curve (AUC) and was found to be 0.90
for major depressive disorder and 0.89 for any depressive disorder. Similarly, the AUCs were
comparable to the HADS (0.89 and 0.86) and WBI-5 (0.91 and 0.88), demonstrating overall
diagnostic accuracy. AUC comparison of the PHQ-2 to the PHQ-9 showed that the PHQ-9 had
superior operating characteristics regarding major depressive disorder (0.95 vs. 0.90) but that
the screens were similar with respect to any depressive disorder (0.90 vs. 0.89). This was not
surprising since the PHQ-9 provides more clinical information and assesses each of the nine
diagnostic features of major depression.
The 520 patients that competed the SCID were also recruited for the 1-year longitudinal
follow-up study. Of the original 520 participants, 167 (83%) were successfully contacted by
telephone the following year and were readministered the SCID, PHQ-2, and PHQ-9 screens.
The sensitivity of the PHQ-2 screen to changes in depression severity was compared to the
reference standard SCID and expressed as the effect size (ES) and standardized response
mean (SRM). The results were categorized into subgroups with the following courses of
depression: major depressive disorder, other depressive disorders, no depressive disorders,
deterioration, and improvement. Follow-up participants were well matched, in that there were no
significant group differences in terms of age, gender, follow-up interval, living with a partner,
educational level, and self-employment. The follow-up SCID assessment found that 52 patients
(31.1%) had improved by the end of the year, 91 (54.5%) had remained stable, and 24 (14.4%)
had a deteriorated condition. That the PHQ-2 scores reflected sensitivity to change was
demonstrated by a large ES, and analogous comparison of the SRM showed similar results
between the SCID and the mean change in PHQ-2 score. In the improved group, an ES of –1.4
(SRM = –1.1) demonstrated a PHQ-2 score change; similarly, in the group with deteriorated
condition, the ES was 0.8 (SRM = 0.7). The mean change in PHQ-2 score in the unchanged
patient group was small (ES = –0.2; SRM = –0.3). Similar results between the ES and SRM
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showed that the PHQ-2 screen accurately reflected different courses of depression over a 1year time frame, and thus that it was sensitive to change.
Over all, this study showed the PHQ-2 to be an accurate and valuable tool for identifying
depression, for making a diagnosis, and for assessing the severity and outcome of treatment
over time. Comprehensive comparison of the PHQ-2 with several commonly used depression
screens showed that the abridged PHQ-2 was as sensitive and specific as longer screens.
Finally, the results showed that a cut-off score ≥3 provided the best trade-off between sensitivity
and specificity. Although the PHQ-9 screen may have been marginally more comprehensive
and diagnostically superior to the PHQ-2, the PHQ-2 was nearly equal in sensitivity and in its
ability to indicate changes over time.
Manea et al. (2016)
Manea et al. (2016) conducted the first meta-analysis and systematic review of the
diagnostic accuracy of the PHQ-2 for identifying major depression in the clinical setting,
examining literature from the EMBASE, MEDLINE, and PsychINFO databases and from
reference lists. Studies that were included used summed-item scoring for the PHQ-2, assessed
scoring against the diagnostic interview, and reported threshold cutoffs of ≥2 and ≥3.
A total of 21 studies met the inclusion criteria, resulting in a patient sample size (N) of
11,175; of these patients, 1529 were identified by diagnostic interview as having major
depressive disorder. Nineteen of the 21 studies reported data for a cut-off of ≥3. At a cut-off
score of ≥3, the pooled sensitivity was 0.76 (95% CI = 0.68–0.82) and pooled specificity was
0.87 (95% CI = 0.82–0.90). Moreover, there was substantial heterogeneity among the studies at
this cut-off (I2 = 81.8%). Seventeen of the studies reported on the performance of the PHQ-2 at
a cut-off of ≥2. The heterogeneity among these 17 studies was lower (I2 = 43.2%); the pooled
sensitivity was 0.91 (95% CI = 0.85–0.94), and pooled specificity was 0.70 (95% CI = 0.64–
0.76).
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The original validation study by Kroenke et al. (2003) recommended a threshold score of
2 because of the higher sensitivity (0.83) compared to a threshold of 3, suggesting that
clinicians would miss fewer cases of depression. However, false-positive results are more
prevalent at lower threshold scores; therefore, the recommended threshold for the PHQ-2 was
increased to ≥3. In clinical settings, where the prevalence of depression is low, a lower
threshold score may result in an unacceptably high frequency of false-positives, which would
overwhelm practitioners with an unnecessary increase in patient encounters.
Manea, Gilbody, and McMillan (2015)
A meta-analysis by Manea, Gilbody, and McMillan (2015) summarized the diagnostic
accuracy of the PHQ-9 for depression in non-psychiatric settings. Manea et al. (2015) compared
application of the PHQ-9 by dichotomist algorithm to the total score of the frequency-test
method for replication in depression diagnosis at the standard threshold score of 10. This study
included systematic reviews and meta-analyses that implemented the PHQ-9 in any setting or
demographic. The evidence search followed the guidelines of the University of New York’s
Center for Reviews and Dissemination, and the literature search include the EMBASE,
MEDLINE, and PsychINFO databases from 1999 to August 2013. Titles and abstracts were
identified by reference to the PHQ-9 screen. The study inclusion criterion was use of PHQ-9
scoring methods compared to the Diagnostic and Statistical Manual or Internal Classification of
Disease (DSM-IV) criteria for major depression (reference standards), for any population or
setting. Quality assessment of relevant studies was conducted based on the revised Quality
Assessment of Diagnostic Accuracy Studies (QUADAS-II). Manea et al. (2015) considered
6,034 studies; of these, 27 met the inclusion criterion and were deemed appropriate for the
review.
This review found that the PHQ-9 algorithm was not a preferred diagnostic method
because it had lower pooled sensitivity (0.58) in identifying depressed patients, although it had
good pooled specificity (0.94). That said, summative scoring had higher pooled sensitivity (0.77)
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and specificity (0.85). This study concluded that the PHQ-9 summed-item score method, used
with a cut-off ≥10, was a better depression diagnostic compared to algorithmic scoring method
(Manea et al., 2015).
Maurer (2012)
An expert opinion piece by Maurer (2012), written on behalf of the American Association
of Family Physicians (AAFP), delineated the clinical recommendations established by the AAFP
for depression screening in practice. Maurer (2012) recommended the PHQ-2 and PHQ-9 as
validated depression screens for clinical practice. The recommendations were graded according
to quality of evidence, as (A) consistent, good-quality patient-oriented evidence; (B) inconsistent
or limited-quality patient-oriented evidence; or (C) consensus, disease-oriented evidence, usual
practice, expert opinion, or case series. The AAFP recommendations included use of the PHQ-2
as a depression screen for adolescents, adults, and older adults; grade B. The AAFP also
recommended the PHQ-9 as a diagnostic follow-up for all positively screened PHQ-2 patients
and to monitor treatment response; grade C. The AAFP recommendations follow the USPSTF
2009 guidelines for adult depression screening and encouraged physicians to routinely screen
patients.
Nimalasuryia, Compton, and Giuillory (2009)
Nimalasuriya, Compton, and Giuillory (2009) prepared an expert opinion piece on behalf
of the Prevention Practice Committee of the American College of Preventive Medicine (ACPM).
The ACPM recognized that depression has a life-threatening effect on 6.7% of the general adult
population, disabling roughly 14.8 million Americans annually. Drawing on the results of
O’Connor, Whitlock, Beil, and Gaynes (2009), the ACPM strongly supported routine depression
screening in the primary care setting as a form of preventative medicine against the known
consequences of depressive symptoms. The ACPM endorsed use of the PHQ-2 and PHQ-9 for
preliminary assessment of depressive symptoms. Based on a systematic review by the AAFP
(2002), the ACPM found both versions of the PHQ to be accurate depression assessment tools
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in the primary care setting. To achieve optimal patient outcomes and remission from depressive
symptoms, the ACPM followed the recommendations of the USPSTF 2002 and 2009 guidelines
for implementation of depression support programs, follow-up protocols, and a collaborative
care approach with specialty mental health services.
O’Connor, Whitlock, Beil, and Gaynes (2009)
This systematic review by O’Connor Whitlock, Beil, and Gaynes (2009) was funded by
the Agency for Healthcare Research and Quality (AHRQ) and examined evidence for
depression screening specific to the primary care setting to update the previous USPSTF
recommendation. O’Connor et al. (2009) developed a 5-question analytical framework that
included these questions:
1.

Is there direct evidence that screening for depression among adults and
elderly patients in primary care reduces morbidity and/or mortality?

2.

What is the effect of clinician feedback of screening test results (with or
without additional care management support) on depression response and
remission in screening-detected depressed patients receiving usual care?

3.

What are the adverse effects of screening for depressive disorders in
adults and elderly patients in primary care?

4.

Are antidepressant use and/or psychotherapy effective at improving health
outcomes for elderly depressed patients?

5.

What are the adverse effects of antidepressant treatment (particularly
selective serotonin reuptake inhibitors [SSRIs] and other second-generation
drugs) for depression in adults and elderly patients? (p. 794)

O’Connor et al. (2009) used USPSTF methods of appraising evidence. The USPSTF
methods follow the National Institute for Health and Clinical Excellence (2004) criteria for study
design and the Oxman (1991) criteria for systematic reviews. Inclusion criteria included: all tests
used were depression screening tests; availability of primary care; an adequate description; use
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of a credible reference standard; interpretation of reference standard independent of screening
test; reasonable handling of indeterminate results; broad spectrum of health conditions and
ages of patients included in study; adequate sample size; and administration of a reliable
screening test. The evidence was rated based on how well it met these criteria and was given a
quality score of good, fair, or poor.
The authors examined 4,088 published abstracts and 412 articles using strict inclusion
and exclusion criteria. Of these, 21 articles were deemed appropriate and synthesized to
answer the key questions. Drafts of the review were appraised by six experts and revised based
on their feedback.
O’Connor et al. (2009) identified no adverse effects associated with routine depression
screening of adults and found that depressive care support programs, including screening,
significantly impacted symptoms and remission frequency in the general adult population.
Depression screening was more effective at identifying depressed patients when resources
such as staff support, educational materials, antidepressants, or mental health referrals were
available in coordination with the primary care provider’s treatment plan. Each of these
resources was available at the EBP project site. Educational materials included patient
handouts on signs and symptoms of depression, from the UpToDate database (see Appendix K
for sample material). This complemented evidence from the previous recommendation in that
the treatment of depression was effective in the general adult population.
USPSTF (2009) Guideline for Screening for Depression in Adults
The clinical guideline set forth by USPSTF (2009), Screening for Depression in Adults:
U.S. Preventative Services Task Force Recommendation Statement and its corresponding
systematic review, Screening for Depression in Adult Patients in the Primary Care Setting: A
Systematic Evidence Review, met the criteria for Level I evidence. The previous USPSTF
recommendation (published in 2002) supported screening adults for depression. This updated
recommendation examined evidence regarding the benefits and risks of depression screening in
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the primary care setting, along with evidence about the effects of depression screening
programs on patient health outcomes (USPSTF, 2009). New items in the updated
recommendation included efficacy of treating depression in older patients, risks of depression
screening in the primary care setting, and adverse events associated with depression treatment
in adults (USPSTF, 2009). The recommendations were based on evidence presented by
O’Connor et al. (2009).
The USPSTF (2009) maintained that screening adults for depression was appropriate
only when staff-assisted depression-care supports were in place to assure accurate diagnosis,
effective treatment, and follow up. This was a grade B recommendation, in that known evidence
was adequate for incorporating this practice into clinical guidelines. Thus, it would be
appropriate for a primary care setting to routinely screen adult patients for depression if
protocols were in place to accurately diagnose, follow up, and treat depression.
The USPSTF based its recommendation on O’Connor et al. (2009) thorough systematic
review of 33 research papers with high-quality evidence; from this review, the USPSTF
projected depression and associated side effects to be among the leading causes of disability in
persons aged 15 and older by 2020. In addition, depression was understood to affect not only
the individual, but also the family, work environment, and interactions with the larger society.
The USPSTF recognized that depression was common in primary care patients, making primary
care clinics an opportune setting for identifying and helping such persons.
Yackel, McKennan, and Fox-Deise (2010)
A pilot study by Yackel, McKennan, and Fox-Deise (2010) evaluated the implementation
of routine depression screening at an Army base primary care center in the Pacific. The aim of
this study was to improve screening and rates of identification of depression in family members
of active-duty soldiers aged 18 or older at a military family practice office. This study instituted a
change in practice and developed a follow-up protocol for individuals identified as having
depression. In addition, education of staff on the process of depression screening improved
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protocol compliance, identification, and documentation of patients with depression. When staff
identified a patient as depressed by the PHQ-2, the protocol algorithm required follow-up by the
patient to complete the PHQ-9. Based on an average of 175 patient visits per day,
implementation of the protocol captured an average of 100 depressed patients per month who
were not previously identified. Based on these results, Yackel et al. (2010) strongly
recommended implementation of a routine PHQ-2 depression screen for adults in the primary
care setting. The results of this study, that application of the PHQ-2 provided accurate
identification of depression, thus demonstrated the need for practice changes around
depression screening. In addition, follow-up protocols in the form of an algorithm provided
consistent practice among clinical staff to ensure homogeneity and sustainability of practice for
optimal quality of mental health care.
Synthesis of Critically Appraised Literature
The critically appraised literature was synthesized to support implementation of this EBP
project. This synthesis delineated evidence in support of routine adult depression screening in
the primary care setting using the PHQ-2 as the initial screening tool and the PHQ-9 as a followup tool to inform diagnosis. Treatment options followed usual practice delineated by the
USPSTF (2009) guidelines for depressed adults.
Evidence for Routine Adult Depression Screening
Clinical guidelines set forth by the USPSTF (2009) recommended routine depression
screening of the general adult population when systems were in place to assure accurate
diagnosis, effective treatment, and follow-up. These guidelines were based on a systematic
review by O’Connor et al. (2009) that found strong evidence that routine depression screening
improved the accuracy of identifying depressed persons in the primary care setting. In addition,
this review found strong evidence that combining routine depression screening with follow-up
scheduling protocols led to significant improvements in early identification of depressed
patients, to swift intervention, and to improved clinical outcomes in young to older adults, and
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that depression screening alone did not improve clinical outcomes in adults or older adult
patients (O’Connor et al., 2009). These recommendations were echoed by AAFP practice
guidelines (AAFP, 2012). Furthermore, O’Connor et al. (2009) found no evidence of risk or harm
associated with depression screening of adults in the primary care setting.
Initial Screening: PHQ-2 as the First Step
The clinical responsibilities of the primary care practitioner are vast with regards to care
and management of pathophysiology, and routine mental health assessment often falls to the
wayside among the plethora of chronic illnesses or acute concerns that must be addressed.
Barriers to routine depression screening in primary care identified by qualitative studies included
that many physicians questioned the utility of structured assessment, viewing the PHQ-9 as
“impersonal and generally less reliable than clinical judgment” (Fuchs et al. 2014, p. 19).
Similarly, a national survey of physicians revealed that physicians tended to selectively apply
depression screens or preferred to rely on clinical judgment alone (Fuchs et al. 2014). National
statistics indicated that the consequences of depression in adults were increasing in severity,
which underscored the importance of integrating routine depression screening into primary care
(Fushs et al. 2014; O’Connor et al. 2009). Institutes such as the AAFP (Maurer 2012), the
NCQA and the ACPM (Nimalasuriya et al., 2009) recommended routine depression screening of
all adults.
The literature supported that the most pragmatic approach to answering the call for
routine adult depression screening was by initial screening within the primary care setting, as
long as follow-up systems were in place when the initial screen was positive. The literature also
concurred that to implement routine depression screening, the instrument length needed to be
realistic and practical for the busy environment of the primary care clinic—it needed to be
accurate, sensitive, and concise. The systematic review by O’Conner et al. (2009) did not find
one depression screen to be superior to another. In general, the PHQ-2 and PHQ-9 screens
were the most popular choices in clinical practice.
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The literature review showed the PHQ-2 to be an accurate, sensitive, and concise
depression screen and, thus, a highly appropriate instrument for the primary care clinic
environment (Arroll et al., 2010; Corson et al. 2004; Fuchs et al. 2014; Gjerdingen et al. 2009;
Kroenke et al. 2003; Löwe et al. 2005; Manea et al. 2016; Maurer, 2012; Yackel et al. 2010).
This screen is an abridged version of the PHQ-9. The two-item version asks about the
frequency of symptoms of depressed mood and anhedonia over the preceding two weeks,
measured by self-reported scoring from 0 (not at all) to 3 (nearly every day; Arroll et al. 2010).
The maximum score for the two-item screen is 6. The PHQ-9 uses the same scale to measure
frequency of symptoms and has a maximum score of 27. The literature found the PHQ-9 to be
the most appropriate tool for diagnostic screening of individuals with a positive PHQ-2 score.
The PHQ-9 is a popular tool in the primary care setting for diagnosis of depression and for
categorization of severity because it was developed for primary care providers and addresses
all the symptoms of depression set forth by the DSM-IV (Kroenke et al. 2003).
Strong evidence from multiple studies endorsed use of the PHQ-2 as an initial, routine
screen for depression in the general adult population in the primary care setting (Arroll et al.
2010; Corson et al. 2004; Fuchs et al. 2014; Gjerdingen et al. 2009; Kroenke et al. 2003; Löwe
et al. 2005; Manea et al. 2016; Maurer, 2012; Yackel et al. 2010). In addition, the AAFP clinical
guidelines (Maurer, 2012) endorsed use of the PHQ-2 as the initial depression-screening tool, to
be followed by the PHQ-9 diagnostic tool when the patient screened positive.
Among these studies, one meta-analysis (Manea et al. 2016), four large randomized
control trials (Arroll et al. 2010; Gjerdingen et al. 2009; Kroenke et al. 2016), one cohort study
(Corson et al. 2004), and one pilot study (Yackel et al. 2010) provided high-quality evidence that
use of the PHQ-2 as an initial screen for depression among the general adult population was
accurate, sensitive, concise, and practical for the primary care setting.
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Positive PHQ-2 Score: ≥3 is Positive
Within the literature, there is some disagreement on what cut-off score is most
appropriate for PHQ-2 depression screening. Corson et al. (2004), Fuchs et al. (2014),
Gjerdingen et al. (2009), Kroenke et al. (2003), Manea et al. (2016), and Yackel et al. (2010)
showed that use of the PHQ-2 as an initial screen for depression in adults was highly accurate
and sensitive at a summed-item cut-off score of ≥3. Overall, a lower cut-off score has not been
shown have a lower specificity and sensitivity in accurately identifying depression (Arroll et al.,
2010).
The principal randomized control trial conducted by Kroenke et al. (2003) demonstrated
that PHQ-2 scores ≥3 had a sensitivity of 83% and a specificity of 92% for identifying major
depression in primary care and obstetric settings. Furthermore, Kroenke et al. (2003) showed
that at a cut-off score of 3, the “PHQ-2 had a likelihood ratio for major depression of 2.92, nearly
identical to the overall likelihood ratio of 2.86 reported for nine other depression case finding
instruments in a meta-analysis of the literature” (p. 1288). In addition, the “PHQ-2 cutpoint of 3
or greater was comparable to the PHQ-9 diagnostic algorithm for any depressive disorder
(kappa of 0.62 vs. 0.58), as well as major depressive disorder (kappa of 0.48 vs. 0.54)” (p.
1288). Based on these results, the optimal cut-off for identifying depression by PHQ-2 summeditem score was standardized as ≥3 (Kroenke et al. 2003).
Gjerdingen et al. (2009) found this standard accurate for early identification of
depression among postpartum women, and the PHQ-2 had a sensitivity of 100% and specificity
of 44%. Likewise, in a cohort study of veterans conducted by Corson et al. (2004), PHQ-2
scores ≥3 had a sensitivity of 91% and specificity of 97%. Similarly, Arroll et al. (2010) found
that PHQ-2 scores ≥2 had a sensitivity of 86% and specificity of 78% for adults in the primary
care setting. These studies demonstrated the accuracy and sensitivity of the PHQ-2 for initial
identification of depression in adults.
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PHQ-9 as Follow-Up for Positive PHQ-2
The literature review demonstrated a consensus that the PHQ-2 was an appropriate tool
for routine initial depression screening in the primary care setting as long as the PHQ-9 was
used as follow-up to assess the severity of depression, as a diagnostic aid, and to facilitate
development of a treatment plan (Arroll et al. 2010; Corson et al. 2004; Gjerdingen et al. 2009;
Kroenke et al. 2003; Yackel et al. 2010). The PHQ-9 was recommended for definitive diagnosis
of depression because it screens for all symptoms established by the DSM-IV (Kroenke et al.
2003). Administration of the full PHQ-9 is not a replacement for clinical judgment. Rather, the
PHQ-9 score helps the clinician to make a more educated decision regarding the most
appropriate plan of care for the patient.
PHQ-9 Score ≥10 for Positive PHQ-2
The systematic review and meta-analysis by Manea et al. (2015) found that PHQ-9
summed-item scores at a cut off ≥10 had better diagnostic performance for depression
screening compared to the algorithm scoring method. In addition, Manea et al. (2015)
recommended PHQ-9 summed-item scoring because this method had better sensitivity, which
is needed in clinical practice. Finally, use of the PHQ-9 with a cut-off ≥10 had greater sensitivity
(77%) and specificity (85%) compared to the algorithm scoring method, indicating that it was
more sensitive and specific for diagnosing major depressive disorder in the primary care setting.
Follow-Up Scheduling Post Initial Positive PHQ-2
The literature indicated that follow-up schedule protocols should be in place for all
positive initial depression screenings to ensure best practice and management of depressed
patients. The recommended time interval between a positive PHQ-2 screen and follow-up by
PHQ-9 varied, ranging from concurrent screening (Arroll et al. 2010; Kroenke et al. 2003) to one
to two weeks after a positive PHQ-2 screen (Gierdingen et al. 2009; USPSTF, 2009; Yackel et
al. 2010). This variation was largely due to the amount of time allotted for each patient
encounter in a busy primary care office or to physician preference and availability to address
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depressive symptoms separately. The USPSTF (2009) designates one-week post-positive
depression screen as an appropriate follow-up interval. Furthermore, the USPSTF (2009)
designates patients started on pharmacologic therapy should be monitored with scheduled
clinical follow-up at least by 4 weeks initiation of drug therapy. These guidelines do not replace
or pre-empt clinical judgments.
Best Practice Recommendation
Over all, the literature review demonstrated that depression was a growing epidemic
among adults and that this epidemic required a pragmatic approach best initiated in the primary
care setting. This approach should include routine screening of adults for depression utilizing
the PHQ-2 tool. A cut-off score of ≥3 was the standardized indicator for more extensive followup that should occur concurrently or within one week of a positive screening. The PHQ-9 was
recommended for assessment and diagnosis of depression at a cut-off score of 10 or greater.
After diagnosis, the clinician follow usual practice, which includes discussion of adverse effects
of depression, options for treatment, and the potential benefits and drawbacks of each option
with the patient as delineated by the USPSTF (2009) depression treatment guidelines.
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How the Best-Practice Model Answered the Clinical Question
The best-practice model answered the clinical question by implementing an EBP
depression-screening tool, the PHQ-2, for early identification of depressed adults. In addition,
development of an EBP follow-up scheduling protocol along with the depression-screening tool
changed current clinical practice and supported the current EBP standards for depression
management in the primary care setting. Finally, this best-practice model assisted the
practitioner in making more informed decisions about management of depression in their
patients and in routinely incorporating mental health assessments into the patient-care protocol.
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CHAPTER 3
IMPLEMENTATION OF PRACTICE CHANGE
The Iowa Model guided implementation of the practice change by translating evidence
from the literature into clinical practice. In addition, Kotter’s ESC (1996) were used to guide
implementation of evidence into practice at the project site. Chapter three describes the
participants and setting, outcomes, intervention, planning, measures, data collection,
management and analysis, and protection of human rights during implementation of the practice
change.
Participants and Setting
The setting for this EBP project was a private family practice clinic located in the
Midwest. The clinic offers medical management for a variety of acute and chronic health
conditions that are addressed at the primary healthcare level. The clinic manages, on average,
4,500 clients annually and has an adult patient population of 3,000. The project population
included adults of all ages but excluded women who were pregnant. The project targeted a
clinical practice; participants included the collaborating physician and affiliated patients.
Implementation of the project took place from mid-December 2016 to mid-January 2017.
Outcomes
The primary outcome of interest for this EBP project was the identification of depressed
adult patients. A second outcome was to measure improvement in organizational practice
according to the number of adult patients that were routinely screened for depression through
implementation of the PHQ-2 screen. A third measurable outcome was to determine the
proportion of positive screens for which practitioner implemented the follow-up scheduling
protocol, which reflected treatment and planning based on the PHQ-2 and PHQ-9 scores. The
final outcome of interest was to measure the success of the depression follow-up scheduling
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protocol in assisting practitioner with developing a plan of care for patients identified as
depressed.
Intervention
Development of this EBP project was guided by the Iowa Model (Titler et al., 2001),
which provides a systematic approach to improving the quality of patient care by melding
research outcomes with clinical practice. As discussed in Chapter 2, the Iowa Model helps
facilitate practitioner engagement from identification of the problem to development of a solution
by translating evidence into clinical practice. The interventions of this EBP project focused on
identifying depressed adults and improving mental health assessments by primary care
clinicians. A thorough literature review provided strong evidence that supported implementation
of this project. As discussed in chapter 2, most of the evidence supported use of the PHQ-2 as
the index screen and the PHQ-9 as a diagnostic follow-up screen to help the clinician make
educated decisions about patients’ plans of care. Additional support for the proposed
interventions was obtained through discussions with the collaborating physician and
management at the project site. Lastly, open discussion and review of the literature indicated
that both the initial intervention and follow-up scheduling protocol were amenable to and
feasible for the EBP project site.
Planning
Kotter’s ESC (1996) approach was used to guide a successful practice change in a
healthcare organization. Like the Iowa Model, the ESC approach incorporates multiple feedback
loops and evaluation stages throughout the process of practice change in order to develop a
viable EBP project. The project intervention targeted clinicians’ practices with implementation of
an organizational-level protocol.
This project was developed after thorough observation of the workflow at the project site
and through conversations with the collaborating physician. To comply with the physician’s
requests, the PHQ-2 screen was performed at client check-in (see Appendix B). An introductory
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letter and informed consent were given to each client to explain the screening and to serve as a
barrier to maintain confidentiality of the patient’s screen (see Appendix C and D). The project
leader scored each of the PHQ-2 screen and all screen results were recorded with the client’s
electronic medical records (see Appendix E). Positive screens were indicated by a summeditem score ≥3 and were noted as “+PHQ2.” For all positively screened patients, the PHQ-9
screen was distributed, scored, and documented in the patient’s electronic medical records by
the project leader (see Appendix F). The PHQ-9 score was used as a depression diagnostic tool
and scored as a reference for depression severity (see Appendix G). Usual care in accordance
to the USPSTF (2009) guidelines determined what treatment was initiated for adults identified
as depressed. Any follow-up appointments that were warranted were noted at the bottom of the
“visit encounter sheet,” and clinicians were responsible for addressing the need for a follow-up
with the client within the coming weeks. Secretarial staff was responsible for handing out a
Client Practice Follow-up Letter and UpToDate ® Patient Depression Education (see Appendix
H and I).
Data
The project anticipated that the number of depressed adults identified would increase
after a routine PHQ-2 screen was introduced into practice, as well as an increase in the
frequency of follow-up scheduling protocol initiations and the number of follow-up encounters
with practitioners. Additional areas of interest were correlations between PHQ-2 and PHQ-9
scores, the type of treatment initiated by clinicians, and demographic information.
Measures
Reliability and validity are independent measures used to determine the reliability and
credibility of research results. Reliability refers to the repeatability and consistency of results,
whereas validity refers to the credibility of research findings (Schmidt & Brown, 2015).

ROUTINE PHQ-2 DEPRESSION SCREEN

54

Reliability
The literature review supported the PHQ-2 as a reliable and valid tool for an index
screen (Arroll et al., 2010; Corson et al., 2004; Kroenke et al., 2003; Löwe et al., 2005; Manea
et al., 2015; Manea et al., 2016) for identifying depression in adults in the primary care setting.
Both the PHQ-2 and PHQ-9 have been found to have excellent reliability, in terms of internal
consistency, with significant Cronbach’s alpha (α) scores of 0.83 (Löwe et al., 2005) and 0.86
(Corson et al., 2004).
Validity
Kroenke et al. (2003) originally determined the construct validity of the PHQ-2 and PHQ9 screens for depression. The construct validity of the PHQ-2 showed a strong linear
relationship between depressive symptoms and increasing PHQ-2 score (P < 0.05) (Kroenke et
al., 2003). The original cut-off score of ≥3 was established based on nearly identical specificity
(0.83 and 0.88), sensitivity (0.90 and 0.88), and likelihood ratios (2.92 and 2.86) for PHQ-2 and
PHQ-9 scores (Kroenke et al., 2003). In addition, ROC analysis (AUC) showed that the PHQ-2
and PHQ-9 were comparable in diagnosing major depressive disorders (0.93 and 0.95,
respectively), and criterion validity provided strong evidence to support use of the PHQ-2 as an
abridged depression questionnaire (Kroenke et al., 2003). Similarly, Löwe et al. (2005) showed
the PHQ-2 screen to be a valid indicator of depression at a cut-off score of ≥3, by replicating
nearly identical ROC analysis (AUC) for diagnosing major depression (0.90) or any depressive
disorder (0.89).
A recent meta-analysis by Manea et al. (2016) detailed the diagnostic validity of the
PHQ-2 at a cut-off score of ≥3 as an index screen for depression in adults through pooled
sensitivity (0.76), specificity (0.87), positive likelihood ratio (6.02), negative likelihood ratio
(0.27), and diagnostic odds ratio (22.20). In addition, this meta-analysis validated the PHQ-9
with a summed-item score of ≥10 as a screen for diagnosing depression in adults that mimicked
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the sensitivity (88%) and specificity (88%) for major depressive disorder originally determined by
Kroenke et al (2003).
Collection
Data were collected at the project site to determine baseline depression screening and
follow-up rates during the same months the year prior to implementation of the project. During
implementation, the project leader performed daily chart audits to evaluate the rate of practice
change. At the end of each week, a list of clients identified as depressed was obtained along
with charts for all clients identified as depressed the previous week. Each of these clients was
then assigned a participant code number (see Appendix J). Each participant’s charts were
reviewed to determine if the PHQ-2 screen was completed, the score received on PHQ-2
screen, distribution of the PHQ-9 screen and total score, the percentage of follow-up
appointments established and completed, and if the project scheduling protocol was
implemented. Demographic data including age, gender, number of chronic disease, history of
substance abuse, risk of isolation, family history of mental health issues, occurrence of a major
life event, potential side effect to current medication regimen, and intervention made by
physician were also collected from client charts.
Management and Analysis
Data on age, gender, PHQ-2 score, PHQ-9 score, number of chronic diseases, history of
substance abuse, risk of isolation, family history of mental health issues, occurrence of a major
life event, potential side effect to current medication regimen, and intervention made by
physician were collected throughout each day and compiled into an Excel spreadsheet (see
Appendix J). All data were de-identified and the program was password protected. Data were
analyzed in SPSS-19, Version 24. Descriptive statistics found included: mean age of depressed
patients, median for chronic diseases, and depression ratio for genders. The Youden index test
was used to determine sensitivity and specificity for the recommended cut-off score for the
PHQ-2 and PHQ-9 screens. A paired sample t-test was used to compare initial PHQ-2 scores
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and to follow-up PHQ-9 scores. The percentage of depressed adults identified before and after
implementation of screening and follow-up was compared as the primary outcome.
Protection of Human Subjects
Prior to project implementation, the project leader completed web-based training and
certification by the IRB through the National Institutes of Health (NIH) course “Protecting Human
Research Participants.” In addition, approval from Valparaiso University’s IRB committee and
for the EBP project site was obtained prior to implementation. Eligible participants included all
non-pregnant adults, aged 18 and older. Data were obtained via daily chart audits. The
confidentiality and anonymity of participants was of the utmost importance and was maintained
to avoid compromising the study results. All participants were de-identified for data collection
and analysis. During the project, all data were kept in a secured location at the project site and
were only accessible to the EBP project leader. At the conclusion of the project, all collected
data were destroyed.
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CHAPTER 4
FINDINGS
This EBP project was designed to determine the effectiveness of routine application of
the PHQ-2 depression screen, along with a scheduled follow-up protocol, for identifying
depression in adult patients seen at a primary care clinic. The goals of the project were to
improve the identification of depression in adult patients at a primary care practice and to
improve upon practices by implementing a standard follow-up protocol.
The PICOT question for this EBP project was: “In primary care practice, how does the
use of a routine depression screening tool (PHQ-2) and follow-up scheduling protocol affect the
identification of and scheduling follow-up with patients with depression, compared to current
practice?” The project was carried out in a family practice clinic in the Midwest. One physician
was recruited at the clinic to pilot this provider-targeted practice change. The provider practice
change included the following: implementation of the PHQ-2 depression screening, use of a
summed PHQ-2 cut-off score of 3 to trigger additional screening with the PHQ-9 screen, and
use of the summed PHQ-9 score to assist clinicians in making plan-of-care decisions per
national guidelines. Data collected during a 1-month timeframe were manually entered in the
Statistical Package for the Social Services (SPSS, Version 23) for analysis. The statistical
analysis assessed the PHQ-2 screen’s accuracy for identifying depression in adult patients and
included the chi-square test of Independence (X2) and Pearson correlations coefficient (r)
between the PHQ screens and demographic variables. Sensitivity and specificity the PHQ-2
screen, with a cut-off score of 3, were previously determined in the literature and will be
reported.
Participants
Individuals’ aged 18 or older, who were not pregnant, and who were affiliated with the
collaborating physician were eligible for participation in this EBP project. All participants were
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given an informed consent agreement and letter of purpose for this EBP project prior to
screening.
Size
During the 1-month implementation period, 301 adult patients received services from the
collaborating physician. Of those 301 patients, 134 (n) participated in the routine depression
screening, resulting a 44.52% participation rate. Of those 134 participants, 73 (54.5%) were
female and 61 (45.5%) were male. Based on the previous literature, race was not accounted for
in this pilot project because race is not a discriminating factor in regards to the occurrence of
depression.
Characteristics
Characteristics for both baseline and implementation populations were filtered by age,
18 years or older, and affiliation to collaborative physician. Baseline population demographics
were limited to the project leader: Only diagnostic depression ICD-10 coding (F32.9) was
provided to the project leader as evidence if diagnosis of depression was made available.
Where as, the implementation population’s demographic data was readily available to the
project leader since the informed consent gave the project leader authority to audit the
participants chart for demographic and depression risk variables.
Baseline period and population. The baseline period, mid-December 2014 to midJanuary 2015, was selected for consistency with the time period 1 year prior for which data
were available; this helped to ensure that external influences such as seasonal depression and
other seasonal stresses would be consistent between the years. Baseline data were filtered to
include patients who had visited the collaborating physician, who were 18 or older, and who had
received the diagnostic ICD-10 code for depression at the time of visit. A total of 572 adult
patients visited the collaborating physician during the baseline timeframe and a total of 20 (3%)
patients were diagnosed with depression based on clinical judgment.
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Implementation population. The EBP project sample population ranged in age from 18
to 93 years old and had a mean age of 57. The number of chronic diseases documented in the
sample population ranged from none to 26, with a mean of 5 active chronic diseases. More of
the sample participants were women (54.5%) than men (45.5%). Race and ethnicity were not
accounted for in the demographic variables because depression does not discriminate.
Demographic characteristics for the implementation population are available in Table 4.1.
Depression. Each participants’ chart was searched for documentation of the following
risk factors for depression: history of physical abuse, history of substance abuse (not including
tobacco), risk of isolation (single or widowed), family history of depression, a current major life
event, and potential medication side effects. Out of the 27 identified participants with
depression: none had a history of physical abuse, none had a history of substance abuse, 4
were at risk of isolation, only 1 had a family history, 7 had a major life event active, and 16 were
on medications with depressive symptoms as a listed side effect. Only 5 participants were found
to have mild suicidal thoughts out of the 27 identified participants with depression. Depression
variables outcomes are available in Table 4.2.
Intervention history. In addition to demographic information and depression risk
assessment, participants’ charts were audited for follow-up appointments scheduled. The time
interval for follow-up scheduling was determined by clinical judgment as to whether the patient
warranted a follow-up appointment. All patients who were identified as depressed (20.15%)
based on the EBP project screen were scheduled for a follow-up appointment (100%).
Changes in Outcomes
The primary outcome of this EBP project was the identification of depression in adult
patients through implementation of the PHQ-2 depression screen. Baseline data consisted of
the number of depressed adult patients diagnosed by clinical judgment and identified per ICD10 code during the same time frame 1 year earlier. During the implementation phase, all
participants were given the PHQ-2 screen after the project leader received their informed
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consent. The PHQ-2 data were scored and charted in the participant’s electronic medical record
by the project leader then were de-identified and recorded in an Excel spreadsheet.
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Table 4.1
Implementation Population Demographics
Demographics
Gender

Frequency (n) Results
54.5% (n= 73) Female
45.5% (n= 61) Male

Age

6.71% (n=9) 18-28 years old
12.70% (n=17) 29-39 years old
19.40% (n=26) 40-50 years old
15.67% (n=21) 51-61 years old
22.39% (n=30) 62-72 years old
19.40% (n=26) 73-83 years old
3.73% (n=5) 84-94 years old

Number of Chronic Disease

52.24% (n=70) 0-5 active diseases
38.06% (n=51) 6-12 active diseases
5.22% (n=7) 13-18 active diseases
3.73% (n=5) 19-23 active diseases
0.75% (n=1) 24-29 active diseases
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Table 4.2
Depression Variable Outcomes
Depression Variable
Gender

Frequency (n) Results
70.37% (n=19) Female
29.63% (n=8) Male

History of Abuse

100% (n=27) No
0% (n=0) Yes

History of Substance abuse (except tobacco)

100% (n=27) No
0% (n=0) Yes

Risk for Isolation (single or widowed)

85.19% (n= 23) No
14.81% (n= 4) Yes

Family History

96.30% (n=26) No
3.70% (n=1) Yes

Major Life Event

74.07% (n= 20) No
25.93% (n= 7) Yes

Medication Side Effect

59.26% (n= 16) Yes
40.74% (n= 11) No

Suicidal ideations

81.48%(n=22) No suicidal thoughts
18.52% (n=5) Yes suicidal thoughts
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The effectiveness of the PHQ-2 screen for identifying depression compared to the PHQ9 screen was assessed statistically in SPSS Version 23 by completing a Pearson correlation
coefficient (r ; see Statistical Testing). The relationship between age and depression prevalence
was analyzed by Pearson correlation coefficient (see Statistical Testing). In addition, internal
consistency of the PHQ-2 screen was examined by completing a Cronbach’s alpha (α) test.
Lastly, a Chi-Square test for independence (X2) was completed to ascertain the relationship
between the PHQ-2 and various demographic variables (see Statistical Testing).
Statistical Testing
The Pearson correlation coefficient was calculated to evaluate the relationship between
the total score of the PHQ-2 screen and the total score of the standard PHQ-9 screen. A
Pearson coefficient of (r (27) = 0.461, p = 0.015) demonstrated a moderate, statistically
significant correlation between the PHQ-2 and PHQ-9’s total scores. This result demonstrates
the PHQ-2 screener correlates with results of the PHQ-9 screen, thus the PHQ-2 screen is an
effective tool for identifying depression among adults.
Cronbach’s α test was used to determine the internal consistency and reliability of the
PHQ-2 screens questions. This statistical test found a Cronbach’s α = 0.904 demonstrating a
strong internal consistency and reliability of this tool for identifying depression in adult patients.
Where as the individual internal consistency and reliability of the PHQ-9 screen was less strong
(Cronbach’s α = 0.536) but moderate nonetheless.
Analyses of the following sub-characteristics were also preformed using chi-square
independent tests: gender, number of active diseases, and each risk factor for depression.
Statistical significance for all analyses was defined as p<0.05. The following depression risk
factors were not statistically significant: gender (X2 = 7.731; p = 0.258), number of active
diseases (X2 = 116.711; p = 0.412), family history of depression (X2 = 6.771; p = 0.343), history
of physical abuse (X2 = 0.842; p = 0.991), history of substance abuse (X2 = 3.416; p = 0.755), or
risk of isolation (X2 = 8.509; p = 0.203). However, with a Pearson correlation, there was a
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significant relationship found between prevalence of depression and a major life event (X2 =
30.776; p = 0.000) and medication side effect (X2 = 31.910; p = 0.000). Age was found to be
significantly correlated with the prevalence of depression (r = - 0.224; p = 0.009). However,
unlike the literature, a weak inverse relationship was found between the age and depression (r =
-0.224; p<0.01, n = 27). Meaning, the younger an individual was the more likely they were to be
depressed within this sample population.
Significance
A simple comparison between the numbers of depressed adults identified before and
after the project implementation showed an increase in the diagnosis of depression. Prior to
implementation of the EPB project, 20 out of 572 patients (3.49%) were identified by clinical
judgment as depressed. During post-implementation, 27 out of 134 total patients (20.15%) were
identified as depressed. Comparison in the improvement of the identification of depressed
adults pre- and post- EBP implementation can be found in Figure 4.1. In addition, the Pearson
correlation coefficient showed a moderate positive correlation (r = 0.461; p<0.05, n = 27)
between the total PHQ-2 and PHQ-9 scores for depression. A comparison of total PHQ-2 to
PHQ-9 scores for each identified depressed patient can be found in Figure 4.2. This meant that
as the total PHQ-2 score increased, so did the total PHQ-9 score, which justified the use of the
shorter PHQ-2 as an appropriate instrument for depression screening. Strong internal
consistency and reliability were calculated for the PHQ-2 screen (Cronbach’s α = 0.904). In
addition, the individual internal consistency and reliability of the PHQ-9 screen was less strong
(Cronbach’s α = 0.536). There was no significant correlation between PHQ-2 total scores and
the presence of risk factors for depression, meaning that each risk factor was independent from
the presence of depression
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Figure 4.1
Improvement in identification of depressed adult pre and post routine PHQ-2 screening
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Figure 4.2
Total score comparison for PHQ-2 to PHQ-9 screens for identified depressed patients
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except for age, a concurrent major life event and a medication side effect. There was a weak
linear relationship between age and total PHQ-2 score (r = –0.224; p<0.01, n = 27); a decrease
in age was associated with depression. The known sensitivity (83-91%) and specificity (92-97%;
Corson et al., 2004; Kroenke et al., 2003) of the PHQ-2 screen is well documented, providing
evidence that the PHQ-2 was an effective tool for depression screening in adult patients. In
summary, implementation of the PHQ-2 depression screen appeared to improve the provider’s
ability to identify depression in the study population as a result of this EBP project intervention.
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CHAPTER 5
DISCUSSION
The purpose of this EBP project was to improving the accuracy of depression
identification among adult patients by implementing a shorter EBP depression tool, the 2-item
Patient Health Questionnaire (PHQ-2). This chapter begins with a discussion of the findings
presented in chapter four. The chapter then evaluates the theoretical and EBP frameworks used
in this project, delineates the project’s strengths and limitations, and examines the implications
of the project findings for future practice, theory, research, and education.
Explanation of Findings
The findings of this EBP project support the routine implementation of the PHQ-2
depression screen, using a cut-off score of 3 or greater, as a means of accurately identifying
adults with depression. In addition, implementation of scheduled follow-up as a practice
guideline for those found to be depressed significantly increased the likelihood of more effective
monitoring for future depressive symptoms.
The project leader closely monitored practitioner adherence to the implemented practice
change. The project leader was required by the organization’s IRB committee to be physically
present during implementation, which made the project manager easily accessible to address
questions or concerns and to monitor application of the practice change. The requirement that
the project leader be physically present limited implementation to 3 out of 4 days in which the
collaborating practitioner was present, resulting in one full day of missed opportunities.
Out of 301 possible adult participants, 134 (N) completed the PHQ-2 screen, for a total
participation rate of 44.5%. The project leader observed that the length of time it took
participants to complete the informed consent process and addition of the introduction letter
were the primary deterrents for those who opted not to complete the screen, thus limiting the
participation rate. The organization’s IRB required an informed consent form to be made
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available for the purposes of the EBP project and insures that participants are aware of the risks
and benefits associated with this EBP implementation.
After data collection was completed, a simple comparison between the numbers of
depressed adults identified before and after project implementation showed an increase in
depression diagnosis in the sample population. Prior to implementation of the EPB project, 20
out of 572 patients (3.49%) were identified by clinical judgment as depressed. During postimplementation, 27 of 134 patients (20.15%) were identified as depressed. The percentage of
identified depressed adults within the sample population mimics the national projected
depression rate for adults in any primary care population. Within the realm of primary care,
depression is estimated to affect 13% of patients (O’Connor et al., 2009). Although depression
is expected to occur in a relatively small percentage of patients, experts project that rates of
depression will continue to increase substantially and that it will be a leading cause of disability
by 2020 (Maurer, 2012). This is because most depression goes undiagnosed, especially in older
adults (aged 60 and older), in whom depressive symptoms are viewed as normal in advancing
age (Unützer et al., 2006). The application of this EBP implementation will improve the accuracy
of depression identification among adult patients, in turn, giving the appearance that the rate of
depression has increased. However, depression is present within the adult population
regardless, it is the accuracy of the PHQ-2 depression screener that will improve the
identification of depression.
Among the older adult demographic, an estimated 10% of general practice patients are
currently undiagnosed for depression (Almeida et al., 2012). According to the U.S. Department
of Health and Human Services (USDHHS; 2012), the U.S. population included 41.4 million older
adults in 2011, an 18% increase since 2000. Because of the increasing prevalence of
depression in the general adult population and the number of undiagnosed older adults in the
United States, family practice is the most promising setting for early identification of, and swift
intervention for, depression.
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Pearson correlations showed a strong positive relationship (r = 0.461; p<0.05, n = 27)
between the total PHQ-2 and PHQ-9 scores for depression diagnoses. These results reflect the
accuracy of the 2-item tool, and they are replicated in similar studies (Arroll et al. 2010; Kroenke
et al. 2003).
No statistically significant relationship was found between the depression risk factor
variables and the prevalence of depression among the sample population. However, there was
a weak yet statistically significant relationship between age and total PHQ-2 score (r = –0.224;
p<0.01, n = 27), where a decrease in age was associated with depression. This results
highlights that age is a risk factor for depression that should not be overlooked by clinicians.
During project implementation, follow-up appointments were scheduled 100% of the time for
participants diagnosed with depression.
The PICOT question, “In family practice, how does the use of a routine depression
screening tool (PHQ-2) and follow-up scheduling protocol affect the identification and follow-up
of patients with depression, compared to current practice?” was answered by this EBP project.
The project demonstrated that implementation of routine PHQ-2 depression screening tool
significantly increased the number of adults who were identified with depression by the clinician,
and the scheduled follow-up visit insured continuity of care. In addition, the project findings
suggested that the commonly assumed risk factors for depression—history of chronic medical
illness, increase in number of chronic disease, family history of depression, history of substance
abuse, and social isolation (NIMH, 2016)—are independent of the prevalence of depression in
this sample.
Applicability of Theoretical and EBP Frameworks
Kotter’s (1996) Eight Stages of Change (ESC) Model was chosen as the guiding
theoretical framework for this EBP project because it focused on change in organizational
practice. Marita Titler’s (2001) Iowa Model of Evidence-Based Practice to Promote Quality Care
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(Iowa Model) was applied as the evidence-based practice model. The following section
evaluates the theoretical applicability of the ESC and Iowa models as the EBP framework.
Theoretical Framework
The ESC model described by Kotter (1996) offers a step-by-step approach to behavioral
change that leads to successful and sustained changes in organizational practice. This process
is considered one of the best approaches to systemic transformation (Pollack & Pollack, 2015),
and, for this reason, this theoretical framework was chosen for this EBP project. The steps
included in the ECS process are to: (1) establish a sense of urgency, (2) create a guiding
coalition, (3) develop a vision and strategy, (4) communicate the vision of change, (5) empower
broad-based change, (6) generate short-term successes, (7) consolidate achievements and
produce more change, and (8) anchor new approaches in the culture (Pollack & Pollack, 2015).
Pollack and Pollack (2015) recognized that organizational transformations in health care could
be successfully achieved by implementing Kotter’s (1996) linear 8-step approach.
Kotter’s ESC model (1996) was very applicable to this EBP project, the focus of which
was to implement a provider-targeted practice change (routine application of the PHQ-2
depression screen at each adult encounter with the practitioner) within an established health
care organization. This practice change varies from current practice, in which the standard is to
apply an annual depression screen or an initial screen when a patient is establishing care.
Through applying steps one through eight of Kotter’s ESC model, a new standard was
implemented in daily practice.
The first step to Kotter’s (1996) ESC process is the establishment of a sense of urgency.
This step is crucial for obtaining the cooperation of those involved and to achieving
implementation of the desired changes. Clinical staff were alerted to the implications of
depression for clinical outcomes, and this knowledge, along with the lack of depression
screening, created a sense of urgency in the context of this project. This initial step proved to be
the springboard behind support for the project.
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In steps two through five, the project leader was in continuous communication with
participants. Step two of the ESC process involves creating a guiding coalition by incorporating
individuals who are involved in the practice change. Since this change took place within an
organization, the guiding coalition was created from various levels of management and clinical
staff. The collation was highly influential in the successful application of this EBP project. The
project leader worked to maintain staff preferences, workflow, and confidence to build a
streamlined application.
Step three included developing a vision and strategy; the project leader had to clearly
present the need for change and a plan of action that involved all members of the guiding
coalition. A successful strategy for systemic change requires the support of leading managerial
staff. Managerial support was obtained by presenting the need for change to those at the
directorial level and by delineating the benefits of the proposed practice changes with the vision
of the EBP project. The project vision was to routinely screen each adult (excluding pregnant
women) with the PHQ-2 while the patient was in the waiting room. Depending on his or her
summed-item score, the patient could be a candidate for further evaluation. The project aim was
consistent with the Healthy People 2020 goal of combating the rising suicide rate in Indiana.
After acquiring managerial support, the strategy for system change involved incorporating the
individuals who will be directly impacted by the change; therefore, the EBP project was
proposed to the clinical staff. Engagement with the entire guiding coalition provided important
insights into the dynamic flow between office personnel and into changes that could be feasible
for the practice. This experience offered the opportunity for staff to openly discuss questions
and concerns with the project leader, which resulted in a better understanding of what could be
realistically accomplished by the project. Overall, this step proved to be the most involved and
challenging for the project leader, with much mediation between the health organization’s IRB
committee and the collaborating physician. This back-and-forth between supporting parties
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revealed potential obstacles, which enabled the project to be purposefully designed to prevent
bottlenecks prior to implementation.
The fourth step of Kotter’s (1996) ECS process is to communicate changes that are
expected to occur. Clear communication promotes understanding about the change process
and is a vital component of organizational transformation (Pollack & Pollack, 2015); change will
not occur unless it is supported by those involved. Evidence supporting the practice change was
discussed at meetings with the collaborating physician and nurse practitioners. This forum
reiterated the need to incorporate routine adult depression screening and follow-up to meet
recommendations for mental health care for adults receiving services at the practice. The needs
of the guiding collation were delineated and a protocol for follow-up scheduling was developed
to address those needs. This protocol included: minimal involvement of auxiliary staff with initial
screening; an initial screening tool that was accurate, of short duration, and easy to score;
follow-up for positive screens during a separate appointment; and a diagnostic tool that was
evidence-based and easy to use. The project leader emphasized that the vision of the EBP
project was to foster a better understanding of the importance of routine depression screening
for adults, the benefits of early identification, and the significance of timely follow-up for those
who suffer silently from depression.
Step five of Kotter’s (1996) process is to remove any factors that could undermine the
project vision (Pollack & Pollack, 2015). To accomplish this, awareness of office flow and of the
potential role and impact of each staff member in the practice change was needed, and
environmental influences needed to be accounted. This was achieved through open discussion
with the guiding coalition and by observation. The primary environmental influence on the
project was timeliness: practitioners could not afford for the patient check-in process to be
slowed down, and the time allotted per patient encounter could not be increased. Second, this
EBP depression tool needed to accurately identify depressed patients, to avoid overwhelming
the office with additional patient appointments for false-positive screens. Keeping these
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limitations in mind, and considering collaborative feedback, a realistic process for applying the
screening tool in this clinical environment was developed. Collaboration with the guiding
coalition and accounting for the realities associated with a busy family practice clinic led to the
generation of an EBP follow-up scheduling protocol that would not inhibit the office workflow and
that would generate positive impacts on practice.
Step six of the ECS is to generate short-term successes, which help to demonstrate the
viability of the practice change and to build momentum for sustainability (Pollack & Pollack,
2015). Kotter (1996) pointed out that short-term wins need to be visible, unambiguously
successful, and clearly related to the direction of change to validate the sacrifice and hard work
of those involved, thus promoting the continuation of efforts toward the desired outcome
(Pollack & Pollack, 2015). Data collected daily on the number of positive depression screens,
the number of follow-up appointments made, and the severity of depression at follow-up were
shared with the guiding coalition. These updates provided insight into the need for adopting a
follow-up scheduling protocol and further insight into progress in implementing the practice
change. Data collection provided an overview of the mental health of the local community, and
data from follow-up appointments provided insight into the impact of the practice change on the
patient community. Short-term successes promoted cooperation and participation by involved
staff, thus increasing momentum toward a successful practice change.
In step seven, the consolidation of gains produced additional change. In this step, all
data and achievements are accounted for at the end of the project implementation period. By
consolidating the data, results are translated into a narrative that describes the overall effect of
the changes in practice. The results of the EBP project reveal whether there are future barriers
to be overcome or whether adaptations need to be made to the follow-up scheduling protocol,
thus producing more change.
Finally, the eighth step of Kotter’s (1996) ESC process is to anchor new approaches in
the culture. Anchoring ensures the sustainability of the implemented change; the new practices
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must be enmeshed into the culture of the organization. The practice change—routine
depression screening with a follow-up scheduling protocol—was a new approach for the project
site, and implementation of this approach aimed to create a new culture by introducing mental
health assessment prior to each patient encounter. Through this process, patients would
become more accustomed to mental health assessment, and clinicians would incorporate
routine depression assessments, without much extra effort by either party. Each of the previous
steps of the ESC process were successfully completed, use of routine depression screening
and follow-up scheduling have become standard practice for the organization, and the EBP
project can be considered successful and viable.
Strengths and Limitations of the Theoretical Framework
The strength of the ESC model as a theoretical framework for this EBP project is that it
provided a clear linear process for implementing an organizational change. Limitations to the
ESC process included that some of the steps may need to be revisited through multiple
iterations depending on the underlying factors encountered. In addition, the ESC process was
largely dependent on input from the guiding coalition, which moved through the stages of the
process at varying speeds depending on the stakeholder.
EBP Framework
In general, EBP describes a model of care guided by evidence-based research, clinical
expertise, and patient preferences (Schmidt & Brown, 2015). By combining these elements, use
of the EBP improves the quality of patient care. Evidence-base practice emphasizes continuous
efforts to reach the highest quality of care by elevating clinical practice. However, changes in
practice required by this process can be unwelcome in the clinical setting.
Evidence-base practice models assist in translating evidence into clinical practice and
require a systematic approach to navigating the multiple interconnected systems that make up a
healthcare organization. An EBP model can serve as a guide for those who are reluctant to
change, and these models facilitate the translation of evidence-based research into clinical
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practice in a timely manner. For these reasons, a model specific to practice changes at the
organizational level—the Iowa Model—was chosen for this project to implement a practice
change in a healthcare organization.
The Iowa Model illustrates how acquired knowledge can guide the implementation of
practice change (Titler et al., 2001), accounting for impacts of the practice change on the overall
healthcare system and including steps to facilitate practitioner engagement in identifying
problems and developing solutions to translate evidence into clinical practice. The three steps in
the Iowa Model that guide EBP practice changes in an organization are to: (1) identify a
problem-focused or knowledge-focused trigger that initiates the need for change and that
indicates the degree to which the change is a priority for the organization, (2) review and critique
the available literature, and (3) identify research evidence that supports the change in clinical
practice (Tilter et al., 2001).
Titler and colleagues (2001) defined a problem-focused trigger as a clinically based
problem or a risk-management issue; whereas, a knowledge-focused trigger is based on new
research evidence or a new practice guideline. This EBP project was initiated by a problemfocused trigger: Mental health assessment was not being performed routinely with patient
exams as encouraged by USPSTF (2009) guidelines. Agreement between clinicians that mental
health assessment was subpar elevated the need for practice change to high priority to provide
the highest quality care. The collaborating physician at the project site formed a team with the
EBP project leader to develop a depression follow-up scheduling protocol. This follow-up
scheduling protocol was also evidence-based and dependent on findings from the literature
review.
Review and critique of the relevant literature (step two of the Iowa Model; Titler et al.,
2001) should indicate whether there is sufficient evidence to warrant a clinical practice change.
For this project, 13 high-quality evidence-based articles were assembled that provided sufficient
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evidence for the need for change. The collection of evidence and the critical appraisal process
were explained in detail in the Literature Search section of this paper.
After a need for practice change was documented, the project leader piloted the change
by (1) selecting the outcomes to be achieved, (2) collecting baseline data, (3) designing EBP
guidelines, (4) implementing EBP at the pilot site, (5) evaluating the process and outcomes, and
(6) modifying the practice guidelines.
To achieve the selected outcomes, the project leader and team determined the number
of patients to be identified in the initial screen, the number of follow-ups needed, the number of
patients diagnosed with depression at follow-up, and the type of follow-up chosen by the
practitioner. They, then, surveyed the practitioners’ awareness of depression before and after
the practice change.
Baseline data collection included the number of patients diagnosed with depressive
symptoms at the EBP site during the same 1-month time period one year earlier, through a
survey of ICD-10 codes. In addition, a pre-EBP project survey about practitioners’ use of the
PHQ-9 depression screen for diagnosis, awareness of symptoms, and effects of depression
was conducted.
The pilot change in practice was the design of the EBP guidelines, which were agreed
upon by the collaborating physician and guided by relevant, high-quality evidence from the
literature. The change to practice included initiation of the PHQ-2 as an initial depression screen
at patient check-in (in the waiting room). A positive cut-off score ≥3 on the PHQ-2 warranted
immediate assessment of the severity of depression symptoms using the PHQ-9. A cut-off score
≥10 on the PHQ-9 indicated major depression. In these cases, the follow-up scheduling protocol
included scheduling a follow-up appointment per the practitioner’s discretion and treatment by
“usual practice,” as delineated by the USPSTF (2009) clinical guidelines.
Implementation of this EBP project occurred after IRB approval was obtained from
Valparaiso University and the affiliated project site and took place from mid-December 2016 to
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mid-January 2017. The pilot unit was a busy, Midwestern family practice clinic that housed three
physicians and two nurse practitioners. Recruited patients were associated with one
collaborating physician.
The EBP project leader managed and evaluated the project implementation process.
Daily evaluation involved collecting PHQ-2 screens from the participating practitioners to
monitor that initial screening was being completed. Each initial screen was scored, the need for
additional screening was determined and distributed by the project leader, and a subsequent
appointment was established at checkout with patients that required further evaluation. During
the pilot project, a follow-up appointment was scheduled for all participants. However, only two
participants had their follow-up appointments during the project time frame, and these patients
were seen by a different provider than the project’s collaborating physician; therefore, the PHQ2 screen was not administered during their follow-up appointment. The remainder of the
participants were scheduled for follow-up appointments with the collaborating physician.
However, unforeseen barriers including a major staffing turnover prevented the project from
continuing beyond the documented timeframe.
The project leader was responsible for considering modification of practice guidelines
during the pilot change in practice. This step took place weekly through face-to-face feedback
from the participating clinician and through practitioner chart audits to monitor utilization of the
PHQ-9, severity of the diagnoses, and treatment choices. Open communication within the team
was maintained to facilitate necessary changes and to address immediate concerns. Overall,
implementation and application went smoothly and the changes were adopted quickly. The
majority of potential challenges were foreseen and ironed out in the third step of the Iowa Model
(the design step).
The third step of the Iowa Model is to determine whether it is appropriate to adopt the
pilot change into practice (Titler et al., 2001). Adoption of the pilot change was dependent on the
achievement of short-term success and resulting descriptive data. The pilot change was
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considered successful based on an increase in the number of depressed patients identified with
the PHQ-2 screen, along with an increase in the frequency of follow-ups appointments
completed by the practitioner. This EBP project was successful and the project findings are to
be disseminated throughout the health care system with the aim of initiating a new practice
protocol and inspiring changes in practice among all primary health care providers.
Strengths and Limitations of the EBP Project
The Iowa Model is commonly used to implement organization-based practice changes. A
major strength of the model is that it provides a systematic approach to translating EBP
evidence into a pilot change in practice.
Strengths
Multiple feedback and evaluation loops enable critical monitoring of the clinician at each
step of the EBP process. The model allowed evidence to be tailored to the practice setting, and
it supported an interdisciplinary team approach, which is realistic and appropriate for healthcare
settings and organization-based changes. This strength was evident in the early development of
the project, and the project leader was able to facilitate agreement between multiple involved
parties. Finally, the model followed a basic problem-solving approach structured after the
scientific process, which made it highly compatible with the realm of health care.
Limitations
Limitations to the Iowa Model included several feedback loops that evaluated the
model’s implementation at various stages of the development process that resulted in multiple
modifications (Melnyk & Fineout-Overholt, 2015). This was evident in the initial development of
this EBP project. However, the early countering between the organization’s IRB and the
collaborating physician proved beneficial and promoted easy application of the project. Each
step of the Iowa Model was critical to customizing evidence relevant to the practice setting and
to promoting adoption within the healthcare system. Although the model was not linear, it
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highlighted the realistic and complex process of implementing an EBP practice change in an
organization.
Implications for the Future
This section of the chapter evaluates the theoretical and EBP frameworks used in this
project, identifies the project’s strengths and limitations, and examines the implications of the
project findings for future practice, theory, research, and education.
Practice. In response to increasing national rates of depression and suicide in adults,
government-based initiatives, such as Healthy People 2020, have prioritized depression
screening at the primary care level. Currently, healthcare systems conduct depression
screening during initial visits and then annually in efforts to meet meaningful-use requirements.
Although current national healthcare practices assess for depression, the results of this EBP
project highlighted the necessity to include mental health assessment at each patient encounter.
Also, with the exception of increased age, the commonly considered risk factors for depression
were correlated with the prevalence of depression. This is a significant finding, in that
practitioners should be even more inclined to complete routine depression screening among the
all ages of the population. Quality of life encompasses all stages of the life cycle. Therefore, at
no age should an individual have to suffer silently with depression.
Although the purpose of this EBP project was to implement routine adult depression
screening, national guidelines do not condone screening without a follow-up protocol. Follow-up
intervals may vary based on the type of intervention taken but do not replace the practitioner’s
clinical judgment. Dissemination of this project’s findings can be utilized to encourage
incorporation of current evidence into clinical practice standards. In addition, implementation of
a practice policy would likely improve clinicians’ adherence to guidelines and the frequency of
mental health assessment. The findings will be disseminated at the affiliated healthcare
organization to determine if research will be extended beyond the pilot study period.
Unfortunately, since this pilot project was completed, the surrounding community has
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experienced several suicides. These local fatalities, although not affiliated with the pilot
healthcare system, have generated a sense of urgency to catalyze implementation of this EBP
practice change across the local healthcare system. The local healthcare organization has
begun to develop a multidisciplinary team aimed at prevention and treatment strategies for
those afflicted by depression within the community.
Theory. Utilization of a theoretical framework, such as the Iowa Model, will prove
invaluable for future efforts in the prevention and treatment of depression within primary care.
The model offers a systematic approach to identify and prioritize problems, search and
synthesize the best evidence from the literature, develop and implement changes to practice,
evaluate the implemented changes, incorporate feedback, and determine if the proposed
changes will be adopted into practice. The Iowa Model has provided a leading theoretical
framework for healthcare-based changes and has been revised twice since its original release.
Changes to the Iowa Model have been made in response to feedback from and changes in the
healthcare industry. The Iowa Model demonstrates the responsiveness and adaptability of
healthcare and will likely continue to be revised in response to this ever-changing industry.
Research. Future longitudinal, multicenter studies should be conducted to determine the
long-term effects of application of routine depression screening and treatment. Future studies
should account for confounding factors that may impact patient recruitment, practitioner
adherence to guidelines, and adaptability to current practice. Future studies should also
consider verbal screening versus paper-based screening. If the policy is adopted into practice at
the affiliated healthcare organization, efforts must be made to conduct periodic literature reviews
to identify new evidence related to adult depression screening and follow-up and to determine
whether it should be incorporated to reflect best practice.
Education. Although patient education was not an intended focus of this study, all
patients who were identified as depressed by the implemented practice change were given an
educational handout about depression along with crisis resources. In addition, those who
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participated in the screening were more likely to inquire about the purpose and benefits of
mental health assessment with the collaborating physician, thus opening lines of communication
with the health professional. Finally, both the practitioner and those who were identified as
depressed as well as those who were currently being treated for depression were presented
with tangible evidence about whether their current treatment was effective, which in turn initiated
conversation about depression management, even if the reasons for the visit did not include
depression.
Conclusion
Depression is a growing healthcare issue that can result in a number of comorbid
complications including death. To reduce the incidence of severe depression, future
interventions must be aimed at both prevention and follow-up management. This EBP project
has demonstrated the benefits of both routine screening and proactive follow-up as the first
initiative in tackling this growing mental health epidemic. Efforts aimed at preventing depression,
such as routine depression assessment, regular patient–provider conversations about mental
health, intervention options, and patient education, including crisis resources, should also be
encouraged and incorporated into current practice. Failure to incorporate evidence-based
practice about depression prevention may have devastating physical and psychosocial
consequences. In summary, this EBP project demonstrated that doctoral-level advanced
practice nurses have the ability and commitment to develop, implement, and evaluate clinical
practice changes to improve patient outcomes and quality of practice, and to become future
change agents in the healthcare arena through the incorporation of evidence-based practice
into standard care.
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organization. After achieving her DNP degree and becoming a board certified family nurse practitioner,
she would like to work in the primary care setting.
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ACRONYM LIST
AAFP: American Association of Family Physicians
ACP: American College of Physicians
ACPM: American College of Preventative Medicine
AHRQ: Agency for Healthcare Research & Quality
APN: Advance Practical Nurse
AUC: Area under the curve
CASP: Critical Appraisal Skills Program
CBT: Cognitive Behavioral Therapy
CDC: Centers for Disease Control
CI: Confidence Interval
CIDI: Composite International Diagnostic Interview
CINHAL: Cumulative Index to Nursing and Allied Health Literature
DF: Degrees of Freedom
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition
EBP: Evidence Based Practice
EMBASE: Excerpta Medical Database
ES: Effect Size
HADS: Hospital Anxiety and Depression Scale
I2: Heterogeneity
ICD-10: International Classification of Diseases, 10th Revision
JBI: Joanna Briggs Institute Clinical Online Network of Evidence for Care and Therapeutics
MEDLINE: Medical Literature Analysis and Retrieval System Online
N: Sample Size
NCQA: National Center for Quality Assurance
NSAIDs: Non-steroidal anti-inflammatory drugs
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SCID: Structured Clinical Interview for DSM-IV
SD: Standard Deviation
SF-12: Twelve-Item Short Health Survey
SGA: Second Generation Antidepressant
SSRI: Serotonin Reuptake Inhibitor
SR: Systematic Review
SRM: Standardize Response Mean
P: Probability
PHQ: Patient Health Questionnaire
PHQ-2: 2-item Patient Health Questionnaire
PHQ-9: 9-item Patient Health Questionnaire
PsychINFO: Psychological Information Database
QUADAS-II: Quality Assessment of Diagnostic Accuracy Studies, 2nd Revision
RCT: Randomized Control Trial
USPSTF: United States Preventative Services Task Force
WBI-5: World Health Organization Five-Item Well-Being Scale
WHO: World Health Organization
>: equal to and greater than
<: equal to and less than
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Appendix A:
Summary of Evidence

Author(s), Citation, Level of
Evidence & Publication Year
Arroll, Goodyear-Smith,
Crengle, Gunn, Kerse,
Fishman, Falloon, & Hatcher.

Design, Sample, Aim
& Procedure
RCT

Validation of PHQ-2 and PHQ9 to Screen for Major
Depression in the Primary Care
Population.

Aim: to validate the 2-item
versus 9-item PHQ
questionnaire for efficiency in
detecting undetected cases of
depression and improve
diagnostic acumen.

Level II
Published: 2010

Sample: 2,642 adult patients

Results of Data or
Evaluation
Results:
PHQ-2 with a threshold score
of 2 or greater: sensitivity
(86%) and specificity (78%) for
diagnosis of depression.
When PHQ-2 threshold score
of 3 or higher: specificity (91%)
and sensitivity (74%).

Scores compared reference
standard, Composite
International Diagnostic
Interview (CIDI)

Corson, Gerrity, & Dobscha

RCT

Screening for Depression and
Suicidality in a VA Primary
Care Setting: 2 Items Are
Better than 1 Item.

Aim: to evaluate the
psychometric properties of
PHQ-2 to PHQ-9 in accurately
diagnosing depression

Level II

Sample: adults (n=1,211)

Published: 2004

Setting: VA primary care
setting

Recommendation for
Clinical Practice
PHQ-2 score of 2 or higher had
good sensitivity but poor
specificity, increase number of
false positives at this threshold.
Practice recommendation:
PHQ-2 accurate for diagnosis
of depression in undetected
cases with a threshold score of
3 or greater.
PHQ-9 with a threshold score
of 10 or greater is accurate in
detection of depressed
patients.

Results:
PHQ-9 reference standard
(sensitivity = 78% & specificity=
88%).
PHQ-2 threshold score >3
demonstrated specificity= 91%
and sensitivity = 97%

PHQ-2 offers accuracy and
brevity.
PHQ-2 offers brevity and
accurate psychometric
properties for depression
screening when compared to
the standard PHQ-9.
PHQ-9 can be used to clarify
severity of depressive
symptoms when the PHQ-2
indicates as score of 3 or
greater.

ROUTINE PHQ-2 DEPRESSION SCREEN

92

Intervention: Patients screened
for depression by 1-item
screen and compared to PHQ2 or PHQ-9 results.
Fuchs, Haradhvala, Hubley,
Nash, Keller, Ashley,
Weisberg, & Uebelacker
Physician Actions Following a
Positive PHQ-2: Impications for
Implementation of Depression
Screening in Family Medicine
Practice
Level IV
Published: 2014

Retrospective Cohort Study
with qualitative survey
Sample: 55 physicians at a
hospital based family practice
clinic
Aim: assess the actual follow
through for depression
diagnosis without a depression
follow up protocol for an initial
positive screening on the PHQ2 by PHQ-9 by physician in
family practice. And assess the
reasons for lack of follow up.

Results:
Retrospective chart review for
previous year identification and
treatment of depression in the
same site of implementation
(N=131 screen positive on
PHQ-2 for new depression,
n=10 were followed up with
PHQ-9 diagnostic).

The retrospective chart review
revealed that the PHQ-2 is
feasibly administered routinely
in a busy primary care setting,
however, without follow up
protocol and physician
education, many patients are at
risk for going under diagnosed
and treated for depression.

Usual care: 5% of PHQ-2
positive screen patients were
follow up by PHQ-9 diagnostic

Results of this survey delineate
that due to the time constraints
and preceding issues, both the
patient and physician would
benefit from a second
appointment to discuss and
further evaluate depressive
symptoms.

Physician survey:
70% of physicians shared they
forgot to consider PHQ-2
results and 62% of those who
indicated a the positive PHQ-2
results state time constraints or
(54%) other needs took
precedence.
96% reported indicated using
“clinical judgment” for mental
health referral; 86% for
medication changes.
89% indicated not
administering the PHQ-9 due
to time constraints, 69% due to
depression “already known” or
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other issue take precedence.
39% of indexed visits noted
time constraints and competing
demands preclude a more
extensive discussion about
depression that could include
the administration of the pHQ-9
and treatment options.
35% indicated the use of PHQ9 “most of the time” to inform a
referral to mental health or to
initiate or change medication.

Gjerdingen, Crow, McGovern,
Miner, & Center
Postpartum Depression
Screening at Well-Child Visits:
Validity of a 2-Question Screen
and the PHQ-9
Level II
Published: 2009

RCT
Sample: 7 Minnesota based
family (4) and pediatric (3)
clinics; n =506 Postpartum
women
Aim: validate the PHQ-2 and
PHQ-9 screen for postpartum
depression among mothers at
family and pediatric clinic
Procedure: Initial screen (PHQ2) at 0-1 month child wellness
exam, reassessed at 2,4,6, and
9-month wellness exams. Initial
screen, if positive, within 2
weeks follow up Structured
Clinical Interview for DSM-IV
diagnoses by PHQ-9
completed.

Results:
Diagnoses with MDD at:
Total = 45 (8.9%);
Majority at 0-1month = 20
(4.6%)
PHQ-2 Likert response:
sensitivity (84%) & specificity
(79%); PPV (28); NPV (98%)
PHQ-9: sensitivity (82%) &
specificity (84%); PPV (33%);
NPV (98%)

PHQ-2 results suggest the use
as an initial screen for
postpartum depression is
accurate in identifying MDD.
PHQ-9 results indicate that use
of the PHQ-9 as a follow up
measure and diagnoses for
positive PHQ-2 results is
accurate.
Supports routine depression
screening with PHQ-2
Supports follow up of positive
PHQ-2 results within 2 weeks
by PHQ-9.
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Kroenke, Spitzer, & Williams

RCT

The Patient Health
Questionnaire-2: Validity of a
Two-Item Depression Screener

Sample: 6,000 adult patients

Results:
Total # of patients found to
have MDD (N=41).

Setting: 8 Primary care office
and 7 obstetric-gynecology
clinics

Total # of patients found to
have any depressive disorder
(N=106)

Aim: evaluate the PHQ-2 to the
original PHQ depression
module and the General Health
Survey (GHS)

PHQ-2 score of 3 or greater:
sensitivity (82.9%), specificity
(90%), positive predictive value
(38.4%), likelihood ratio (2.9)

Level II
Published: 2003

Löwe, Kroenke, & Grafe
Detecting and monitoring
Depression With a Two-Item
Questionnaire (PHQ-2).

Intervention: All patients
completed the GHS and full
PHQ. Physicians were
unaware of previous scores.
The intervention group
answered the PHQ-2 per
interview with the physician.
Results were compared.
Cross-Sectional Cohort Study
Sample: 1619 patients
Setting: 7 outpatient clinics and
12 family practices

Level IV
Published: 2005

Aim: validate the PHQ-2
compared to the DSM-IV SCID
Intervention: Patient competed
PHQ-2 and every 3rd patient
also completed DSM-IV SCID.

Validated PHQ-2 as an
accurate tool for initial
depression screener for adult
primary care patients.
Recommendation is follow up
positive PHQ-2 screens with
diagnostic PHQ-9 for severity
of symptoms.
Recommends a cut off score
equal to 3 or greater on the
PHQ-2.

Measure: Chi-square test and
one-way analysis variance

Overall, PHQ-2 demonstrated
reliable use in clinical practice
for depression screening and
Results: PHQ-2 r = 0.67 to 0.87 over time.
PHQ-2 cut off score of > 3
showed best sensitivity (87%)
and specificity (78%) for MDD
and any depressive disorder.

PHQ-2 cut off score of > 3 best
for sensitivity and specificity
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Patients were categorized by
SCID scoring (MDD, other
depressive disorder, or no
depressive disorder). Patients
were reassessed by PHQ-2 12
months later.
Manea, Gilbody, Hewitt, North,
Plummer, Richardson,
Thombs, Williams, & McMillan
Identifying depression with the
PHQ-2: a diagnostic metaanalysis
Level I
Published: 2016

Manea, Gilbody, & McMillan
A diagnostic meta-analysis of
the Patient Health
Questionnaire-9 (PHQ-9)
Algorithm Scoring Method as a
Screen for Depression
Level I
Published: 2015

Meta-analysis & Systematic
Review
21 studies
Cumulative patient sample
11,175
Aim: determine the PHQ-2
diagnostic accuracy in
identifying major depression at
a cut off score of 2 and 3 or
greater

Meta-analysis & Systematic
Review
27 studies
Aim: Perform a systematic
review on the diagnostic
accuracy for MDD by the PHQ9 algorithm scoring versus
summed-item scoring at the
proposed cut off score of > 10.

Results:
19 studies reported data for a
cut-off point of ≥3; Pooled
sensitivity was 0.76 (95% CI
=0.68–0.82), pooled specificity
was 0.87 (95% CI =0.82–0.90).
Substantial heterogeneity at
this cut-off (I2=81.8%).
17 studies reported data on the
performance of the measure at
cut-off point ≥2; Heterogeneity
was lower (I2=43.2%); Pooled
sensitivity was 0.91 (95% CI
=0.85–0.94) and pooled
specificity was 0.70 (95% CI
=0.64–0.76). Risk of more false
positives
Quality Assessment: QUADASII guidelines
Pooled Algorithm PHQ-9
scoring sensitivity (53%),
specificity (94%), positive
likelihood ration 10.20,
negative likelihood ration 0.48,
DOR was 20.96
Pooled Summative PHQ-9

Recommends summed-item
scoring for PHQ-2 at a
threshold cut off score equal to
3 or greater for less false
positives.

Summed-item score method, at
a threshold score of 10 or
greater, is a better diagnostic
performance for depression
screening purposes or when
high sensitivity is needed.
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Review followed guidelines and
recommendations stipulated by
the Centre for Reviews and
Dissemination. Diagnostic
systematic review of the
available literature using
bivariate meta-analysis
methods.
Literature search: EMBASE,
MEDLINE, PsycINFO from
1999 to 2013.

Maurer
Screening for Depression:
American Family Physician
Level VII
Published: 2012

Nimalasuryia, Comptom, &
Guillory

Inclusion criteria: any
population, any setting, pHQ-9
tool used, guided clinician
diagnoses for MDD.
Clinical Guideline & Expert
Opinion for the American
Association of Family
Physicians
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scoring sensitivity (77%),
specificity (85%), positive
likelihood ratio 5.54, negative
likelihood ratio 0.25, DOR
21.53
Pooled sensitivity scoring for
PHQ-9 algorithm scoring
method was lower versus the
summative scoring method
Heterogeneity (I2 = 59.8%) was
consistently high between both
methods of applying instrument
in diagnosing of depression in
the primary care setting

Peer reviewed references

Aim: Supports routine primary
care depression screening.
Supports 2-item PHQ
questionnaire for depression
screening. Supports the use of
the PHQ-9 as a follow
diagnostic for positive PHQ-2

Expert opinion by American
College of Preventive Medicine

Peer reviewed references.

Recommendations: PHQ-2 for
depression screening in
adolescents, adults, and older
adults. [Grade B]
The PHQ-9 is a valid, quick
screening instrument for
depression that also can be
used as a follow up to a
positive PHQ-2 result and to
monitor treatment response.
[Grade C].
Supports the USPSTF (2009)
depression screening
recommendation within primary
care setting.
Recommends all primary care
screen for depressive
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Screening Adults for
Depression in Primary Care: A
Positive Statement of the
American College of
Preventive Medicine

Aim: Supports routine primary
care depression screening.
Supports 2-item PHQ
questionnaire for depression
screening

Level VII
Published: 2009

Remission from depression
should be the endpoint, not just
treatment in primary care.

O’Connor, Whitlock, Beil, &
Gaynes
Screening for Depression in
Adult Patients in Primary Care
Settings: A Systematic
Evidence Review
Level I
Published: 2009

Systematic Reviews
33 Articles included in review:
RCTs, SRs, MA, and large
observational studies
Literature search: Medline,
Cochrane Central Register of
Controlled Trials, Cochrane
Database of Systematic
Reviews, Data base of
Abstracts of Reviews of
Effects, PsycINFO (1998 to
2007), expert suggestions, and
bibliographies or recent
systematic reviews
Data Extraction: 2 investigators
independently abstracted,
critically appraised, and
synthesized evidence
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symptoms on a routine basis
as long as adequate follow up
measures are available.
Supports USPSTF (2009)
depression screening
recommendation.
Follow up protocol necessary
for best patient outcomes.

Quality Assessment: guided by
USPSTF methods and the
National Institute for Health
and Clinical Excellence criteria
9 good quality evidence trials
indicate that primary care
depression screening and care
management programs with
staff assistance; Benefit was
not evident in screening
programs without staff
assistance in depression care.
7 regulatory reviews or metaanalyses and 3 large cohort
studies indicate no increased
risk for completed suicide
deaths with antidepressants
treatment. Risk of suicidal
behaviors was increased in

Collaborative care between
PCP and specialties services is
best approach for positive
patient outcomes.
Recommendation: Depression
screening programs without
substantial staff-assisted
depression care support is
unlikely to improve depression
outcomes.
Close monitoring of all adult
patients who initiate
antidepressant treatments,
particularly those younger than
30 years, is important both for
safety and to ensure optimal
treatment.
No evidence was found that
indicated harm of screening for
depression in general adults or
older adults population.
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Inclusion criteria: English
publications from 1998 to 2007,
full reports, primary care
setting, harms of treatment,
adverse effects associated with
treatment, young adult to older
adult population.
Sponsor: USPSTF
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young adults (18 to 29 yo) who
received antidepressants,
particularly those who received
paroxetine, but was reduced in
older adults.
Patients who where depressed
at baseline, screened patients
were more likely than
unscreened patients to be in
complete remission at followup (< 1 symptoms of
depression in 48% of those
screened vs. 27% of those not
screened; P< 0.05).

U.S. Preventive Services Task
Force Clinical Guideline

Clinical Guideline & Systematic
Review

Grading: guided by USPSTF
grading criteria

Screening for Depression in
Adults: U.S. Preventive Service
Task Force Recommendation
Statement

33 Scientific studies

Quality Assessment:
classification guided by
USPSTF levels of certainty
about net benefit.

Level I
Published: 2009

Inclusion criteria: New areas of
evidence considered for (and
not reviewed in 2002) include
efficacy of treatment of
depression in older adult
patients, harms of screening
depression in primary care
setting, and adverse events
from treatment of depression in
adults.
Limitation: This systematic
review did not reexamine
evidence for those key
questions that had strong,

Results:
No evidence of harms of
screening for depression in
adults or older adults.
Early identification of
depression beneficial.
2 question screening is
supported for depression
screening

Recommendation: Guideline:
Screening adults for
depression when staff-assisted
depression care supports are
in place to assure accurate
diagnosis, effective treatment,
and follow up. [Grade B].
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Treatment with SSRIs exercise
caution in 18-29 due increase
risk of suicidal behaviors.
SSRIs and NSAIDS increased
risk of GI bleeds in older
adults.

Yackel, McKennan, & FoxDeise
A Nurse-Facilitated Depression
Screening Program in an Army
Primary Care Clinic
Level III
Published: 2010

Pilot Study non-RCT
Aim: to implement routine
depression screen and
algorithm in primary care clinic,
and to test the efficacy of a
systematic depression
screening program in family
members of active duty
soldiers (+18 yo) at a military
family practice clinic.
Integrated PHQ-2 and PHQ-9
as routine depression
screening in primary care
encounters.

Optimal interval for depression
screening unknown.
Results:
Identification of undetected
depressed patients average
100 patients monthly.
3 months into implementation,
27% of patient encounters
were identified as depressed

Recommendation: Depression
screening and depression
support programs integration
into primary care is beneficial
to patient care outcomes.
Use of the PHQ-2 and PHQ-9
are accurate and efficient tools
for depression screening for
the primary care setting and
identifying depressive
symptoms among undetected
adults.
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Appendix B
PHQ-2 Screen Sample
The PHQ-2 screen used in this study is presented below.
Please circle the category that applies to your feelings over the past 2-weeks:
Over the past 2
weeks, how often
have you been
bothered by any
of the following
problems:

Not at all

Several Days

More than Half
the Days

Nearly Every
Day

1.) Little interest or
pleasure in doing
things?

0

1

2

3

2.) Feeling down,
depressed, or
hopeless?

0

1

2

3

*Adapted from: Drs. Robert L Spitzer, Janet B. W. Williams, Kurt Kroenke and colleagues, with an educational grant from Pfizer Inc.
No permission required reproducing, translating, displaying or distribute.

For medical personnel only:
PHQ-2 Total Score: _______________
MRN: __________________________
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Appendix C
Patient Consent Agreement
Project Title: The Effect of Routine PHQ-2 Depression Screening and Schedule Protocol in the
Primary Care Setting
Evidence-Based Practice (EBP) project manager: Alex Bikowski, Registered Nurse, Saint Joseph
Health Systems, DNP student Valparaiso University
Procedure: The purpose of this EBP project is early identification of depression in non-pregnant
adult patients. The EBP project manager/ DNP student will obtain demographic data, lifestyle history
from electronic medical records along with depression screening score results. The obtained
depressive symptom data will be analyzed using the 2-item and 9-item Patient Health Questionnaire.
Data collection with take place over a 12 week period. Participants who are identified as depressed
will be notified to make a follow up appointment with their healthcare provider to discuss the results
of the screening.
Risks: There are no potential physical risks associated with depression screening. Potential risks
may include psychological distress with depression identification.
Benefits: Participants in the project will be assessed for their individual risk for depression. By early
risk identification and stratification, participants can focus on modifiable risk factors that may prevent
or delay progression of depressive symptoms. Early identification of depression will maintain health
and decrease health care costs. The objective is to improve health and health outcomes.
Voluntary Participation: I understand that participating in this EBP project is my choice and I am free
to withdraw at any time without consequence. In the event I refuse to participate will involve no
penalty or loss of benefits to which the subject is otherwise entitled and the subject may discontinue
participation at any time without penalty.
Questions: If I have any questions about participating in this EBP project now or in the future, Alex
Bikowski RN can be contacted at 505-480-8368. If I have any questions or concerns regarding my
rights as a participant, Saint Joseph Regional Medical Center IRB Chairperson, Jason Jablonski at
574 -335-2525, Dr. Rasha Abed, Chair of the Institutional Review Board at Valparaiso University can
be contacted at 219-464-5798 or my academic advisor Dr. Amy Cory at 219-464-5296.
Confidentiality: Although the answers I provide and the screening I consent to may be used and
reported by the EBP project manager, my name and other identifiable information will be kept strictly
confidential.
Consent to participate: I have read or have had read to me all of the above information about this
project, the procedure, possible risks, potential benefits to me, and I understand them. All of my
questions have been answered and I freely give my consent and agree to participate in this project.
Participant signature:___________________________Date & Time:___________________

EBP project manager signature:___________________Date & Time:___________________
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Appendix D
Introductory Practice Improvement Notice

Dear Client,
Dr. Miller and his colleagues are trialing a new practice standard in order to improve the
quality of care provided to this patient population. The following page entails a confidential and
self-reported survey regarding your emotional and mental health. The purpose of this survey is
to provide more comprehensive assessment of your well-being in combination with your
physical encounter at today’s visit.

Please take a few moments to answer the four questions on the following page.

Thank you,
Clinical Team
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Appendix E
PHQ-2 Scoring Grid & Protocol

PHQ-2 Score

Protocol

Total Score 0–2

No further evaluation warranted

Total Score ≥3

Administer PHQ-9 post completion of PHQ-2
screen for further evaluation.
Notify practitioner of need for follow-up
appointment for depressive symptoms.

Refusal

Notify project leader as soon as possible

*Adapted from: Drs. Robert L Spitzer, Janet B. W. Williams, Kurt Kroenke and colleagues, with an educational grant from Pfizer Inc.
No permission required reproducing, translating, displaying or distribute.
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Appendix F
PHQ-9 Screen
Nine-Item Patient Health Questionnaire (PHQ-9)

Over the last 2 weeks, how often have you been bothered by any of the following?:
Not at
all

Several
days

1. Little interest or pleasure in doing
things
2. Feeling down, depressed, or
hopeless
3. Trouble falling or staying asleep, or
sleeping too much
4. Feeling tired or having little energy
5. Poor appetite or overeating
6. Feeling bad about yourself – or
that you are a failure or that you
have let yourself or your family
down
7. Trouble concentrating on things,
such as reading the newspaper or
watching television

0

8. Moving or speaking so slowly that
other people could have noticed.
Or the opposite – being so fidgety
or restless that you have been
moving around a lot more than
usual.
9. Thoughts that you would be better
off dead, or of hurting yourself.

(Please circle your answer choice)

1

More than
Half the
days
2

Nearly
every
day
3

0

1

2

3

0

1

2

3

0
0
0

1
1
1

2
2
2

3
3
3

0

1

2

3

0

1

2

3

0

1

2

3

Add columns: ________ + ________ + ________ + ________
TOTAL: ______________
(Healthcare Professional: For interpretation of TOTAL, please refer to accompanying scoring card)

10. If you circled any problem, how difficult have
these problems made it for you to do your
work, take care of things at home, or get
along with other people?

Not difficult at all
Somewhat difficult
Very difficult
Extremely difficult

_______
_______
_______
_______

*Adapted from: Drs. Robert L Spitzer, Janet B. W. Williams, Kurt Kroenke and colleagues, with an educational grant from Pfizer Inc.
No permission required reproducing, translating, displaying or distribute.
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Appendix G
PHQ- 9 Scoring Card
Interpretation of PHQ-9 Total Score
Total Score

Depression Severity

Action Taken

0-4

Minimal depression

None

5-9

Mild depression

Watchful waiting; repeat PHQ-9 at follow-up

10-14

Moderate depression

Treatment plan, consider counseling, follow-up and/or
pharmacotherapy

15-19

Moderately severe
depression

Active treatment with pharmacotherapy and/or
psychotherapy

20-27

Severe depression

Immediate initiation of pharmacotherapy and, if
severe impairment or poor response to therapy,
expedited referral to a mental health specialist for
psychotherapy and/or collaborative management

*Adapted from: Drs. Robert L Spitzer, Janet B. W. Williams, Kurt Kroenke and colleagues, with an educational grant from Pfizer Inc.
No permission required reproducing, translating, displaying or distribute.
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Appendix H
Positive PHQ-2 Screen Follow-up Schedule Notification Letter
Dear Client,
Thank you for participating and assisting this office’s efforts to better serve our patient
population. Based upon your responses to our 2-item Patient Health Questionnaire (PHQ-2) you
may or may not be asked to schedule a follow-up appointment. If so, this second appointment is
to assist our clinicians improve their comprehensive health practices. Follow-up appointments
will entail a one-on-one discussion with your clinician. We look forward to seeing you again
within the next two weeks.
If you have any mental health concerns, please do not hesitate to contact this office to
schedule an appointment. All aspects of your health are our concern, including mental health.
Below are available online resources for your reference regarding mental health:
Stress Coping: https://patienteducation.osumc.edu/Documents/stress-management.pdf
Grieving Coping: https://patienteducation.osumc.edu/Documents/grief.pdf
Depression: http://www.cdc.gov/mentalhealth/basics/mental-illness/depression.htm
OR https://patienteducation.osumc.edu/Documents/depression.pdf
Anxiety: http://www.patienteducationcenter.org/articles/generalized-anxiety-disorder/

Thank you for allowing us to learn to serve you better and improve upon our clinical skills.
Sincerely,
Clinical Team
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UpToDate ® Patient Education Take Home Material (English)
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1

2

3

4

5

6

7

8

9

1

0

S/E
MEDICATI
MAJOR
O
EVENT
F/U

# HX
CHRONIC
FAM HX
DISEASE
ISOLATIO

AGE

GENDER

PHQ-9
Q10

PHQ-9
Q9

PHQ-9
Q2

PHQ-9
Q1

PHQ-9
SCORE

PHQ-2
Q2

PHQ-2
SCORE
PHQ-2
Q1

CODE

MRN
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Appendix J

Code Book Sample
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Appendix K
Depression Screen and Follow-up Schedule Protocol Algorithm
Figure K

Patient given PHQ-2 at check-in

PHQ-2 Screen

PHQ-2 Screen

summed-item score equal to 3 or greater**

Summed-item Score of eqaul to 2 or less

Distribute PHQ-9 Screen
No Intervation Necessary
Treatment as usaual

PHQ-9 Screen Summed
Item score equal to 10
or greater**

PHQ-9 Summed-item
score equal to 9 or
less

PHQ-9 positive for severe
Suicidal Ideations Immediate ED admission
by supervised staff escort
per USPSTF (2009)
guidelines

Treatment as usual:
Initiate depression treatment
per USPSTF (2009) guidelines
& clinical judement
Schedule Follow-up
appointment

Treatment as usual

